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 A very large and growing number of individuals worldwide suffer from 
Alzheimer's disease (AD). Early diagnosis is paramount to achieving optimal 
effectiveness for disease-modifying treatments. 
 To date, the predictive value of cortical thickness and the shapes of 
hippocampus and thalamus has been underinvestigated. Therefore, the aim 
of the first study was to investigate these measures as potential indicators of 
AD progression in cognitively healthy elderly subjects.  
 The second study features a design with two time points and 
investigated the predictive value of striatal and thalamic shape as well as 
cortical thickness for conversion from mild cognitive impairment (MCI) to 
dementia due to AD. 
 Resting state functional MRI (rsfMRI) studies have shown differences 
in functional connectivity between individuals with AD and healthy control 
subjects. However, relatively subtle aspects of study design have a significant 
impact on connectivity measures, hampering reproducibility of results across 
research groups. Hence, the third study investigated whether participant 
information influenced subsequently measured functional connectivity within 
and between networks. 
 The present rsfMRI study contributes to reproducibility and 
comparability of results across research groups. The other two studies yielded 






 Eine sehr grosse und zunehmende Zahl von Personen weltweit leidet 
an der Alzheimerkrankheit. Daher ist eine frühe Diagnose unverzichtbar, um 
ein optimales Behandlungsergebnis zu erreichen. 
 Bisher wurde der Vorhersagewert von kortikaler Dicke und Formen von 
Gehirnstrukturen zu wenig untersucht. Deshalb war das Ziel der ersten 
Studie, diese Masse als potenzielle Indikatoren des Fortschreitens der 
Alzheimerkrankheit in kognitiv gesunden älteren Personen zu untersuchen. 
 Die zweite Studie weist ein Design mit zwei Zeitpunkten auf und 
untersuchte die Vorhersagekraft striataler und thalamischer Form sowie 
kortikaler Dicke für die Konversion von leichter kognitiver Beeinträchtigung zu 
Alzheimerdemenz.  
 Studien zu fMRT im Ruhezustand zeigten Unterschiede in funktioneller 
Konnektivität zwischen Personen mit Alzheimerdemenz und gesunden 
Kontrollprobanden. Jedoch beeinflussen bereits subtile Aspekte des 
Studiendesigns Masse von Konnektivität signifikant, was die 
Reproduzierbarkeit durch andere Forschungsgruppen einschränkt. Daher 
wurde mit der dritten Studie untersucht, ob Information der Teilnehmenden 
die nachfolgend gemessene Konnektivität innerhalb und zwischen 
Netzwerken beeinflusste. 
 Die vorliegende fMRI-Studie trägt zur Reproduzierbarkeit und 
Vergleichbarkeit von Resultaten bei. Die anderen zwei Studien brachten 
vielversprechende Resultate für hippokampale und thalamische Form als 
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 Globally, the number of individuals with dementia was estimated to be 
47 million in 2016. According to the World Alzheimer Report of said year, this 
number is expected to increase to over 131 million by 2050 due to population 
aging. Dementia also has a huge economic impact. The total estimated 
worldwide cost of dementia is US$ 818 billion, and it will become a trillion 
dollar disease by 2018 (Prince, Comas-Herrera, Knapp, Guerchet, & 
Karagiannidou, 2016). The most common cause of dementia is Alzheimer's 
disease (AD), which accounts for 60 to 80 percent of cases (Alzheimer's 
Association, 2017). AD is characterized by gradual onset of cognitive decline, 
usually involving impairments in learning and recall of recently learned 
information, and progression from mild cognitive impairment (MCI) to 
dementia, involving cognitive or behavioral impairment in two or more 
domains and interfering with activities of daily living or work (McKhann et al., 
2011). In addition to its gruesome effect on the lives of individuals with the 
disease, AD takes a heavy toll on the social surroundings of patients, with an 
estimated 18.2 billion unpaid hours of care given to people with dementia in 
2016 in the United States alone (Alzheimer's Association, 2017).  
 Despite its large burden on society, there is no cure for AD. Currently, 
the approved treatments are the cholinesterase inhibitors rivastigmine, 
galantamine, and donezepil for mild to moderate AD (Birks, 2006) and the N-
methyl-D-aspartate receptor antagonist memantine (McShane, Areosa Sastre, 
& Minakaran, 2006). However, these treatments target cognitive symptoms 
rather than the underlying pathophysiological process. Clinical research has 
therefore shifted to disease-modifying treatments that interfere with specific 
steps of the pathogenic cascade (Galimberti & Scarpini, 2011), such as the 
antibody aducanumab triggering the clearance of Aβ plaques (Sevigny, 
Chiao, Bussiere, et al., 2016; Sevigny et al., 2017). Such disease-modifying 
treatments are thought to be most effective when applied in preclinical stages 
of AD (Counts, Ikonomovic, Mercado, Vega, & Mufson, 2017; Laske et al., 
2015; Masdeu, Kreisl, & Berman, 2012; Villemagne et al., 2013), and Aβ-
modifying therapies are thought to profit particularly from initiation before the 
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onset of neuronal degeneration (Sperling, Aisen, et al., 2011). Because the 
AD pathophysiological process is thought to begin many years before the 
onset of cognitive symptoms, with abnormal Aβ levels in the brain more than 
15 years before the onset of dementia (Villemagne et al., 2013), the search 
for biomarkers that reliably predict AD progression before the onset of 
cognitive symptoms is of great importance. 
 In this chapter, the most important pathological features of AD as well 
as criteria for diagnosis of MCI and dementia due to AD will be described. 
Additionally, the current state of preclinical biomarker research will be 
summarized and the current role of structural and functional MRI for prediction 
of AD progression will be outlined. Chapter 2 includes information about the 
methods applied and the measures analyzed in the three studies comprising 
this thesis, followed by Chapter 3 outlining the aims and hypotheses of each 
study. Chapter 4 presents the empirical studies, whose results will be 
discussed in chapter 5, which includes elaborations on their implications for 
the field of AD biomarker research as well as limitations and possible avenues 
of future investigations. 
 
1.1 The two key neuropathological features of AD 
 AD is characterized by the presence of a number of pathological 
features including astrogliosis, microglial cell activation, granulovacuolar 
degeneration and Hirano bodies (Serrano-Pozo, Frosch, Masliah, & Hyman, 
2011). Yet, the two most prominent AD hallmarks are the extracellular 
deposition of insoluble Aβ aggregates and the intracellular accumulation of 
neuritic plaques, neurofibrillary tangles (NFT), and neuropil threads (H. Braak 
& Braak, 1991b), both of which must be observed in post-mortem pathology 
for a definitive diagnosis (Hyman et al., 2012; Hyman & Trojanowski, 1997). 
Aβ plaques form as a consequence of the misfolding of Aβ peptides, whereas 
tau aggregates form as a result of the misfolding of microtubule-associated 
protein tau (Nussbaum, Seward, & Bloom, 2013). It is unclear whether 
amyloid or tau pathology occurs first in the neuropathological cascade of AD, 
but both processes start long before symptom onset (H. Braak, Zetterberg, 
Del Tredici, & Blennow, 2013; Jack et al., 2013; Villemagne et al., 2013). 
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Parameters of amyloid and tau pathology can be measured in vivo in the 
cerebrospinal fluid (CSF) after lumbar puncture, or in the brain by PET, using 
a suitable radioligand. 
 
1.2 Preclinical AD, MCI, and dementia due to AD 
 In their 2011 revision of the 1984 criteria for the clinical diagnosis of 
AD, the National Institute on Aging (NIA) and the Alzheimer's Association 
(AA) provided recommendations on AD diagnosis for three distinct phases of 
the disease course: the preclinical asymptomatic phase, the pre-dementia 
symptomatic phase, and the dementia phase (Jack et al., 2011). One working 
group developed a research framework for the preclinical, or presymptomatic, 
phase of AD (Sperling, Aisen, et al., 2011), one working group developed 
criteria for the symptomatic pre-dementia phase, MCI (Albert et al., 2011), 
while another working group developed criteria for the dementia phase 
(McKhann et al., 2011).  
 
 Preclinical AD 
 The proposed research framework proposed for preclinical AD by the 
responsible NIA-AA working group includes three stages. The first stage is 
characterized by amyloid positivity, established by PET neuroimaging 
evidence of Aβ accumulation or low CSF Aβ42 levels, in the absence of 
biomarkers of neurodegeneration and cognitive or behavioral symptoms. 
During the second stage, amyloid positivity is accompanied by such measures 
of neuronal injury, including elevated CSF total tau or phospho-tau, AD-typical 
hypometabolism observed by 18fluorodeoxyglucose (FDG) PET, gray matter 
loss in an AD-typical spatial pattern or hippocampal atrophy observed by MRI, 
and possibly fMRI connectivity measures of the default mode network. The 
third stage, in addition to amyloid positivity and early neuronal injury, includes 
subtle cognitive decline in relation to a previously established baseline with 





 The clinical syndrome constituting MCI due to AD described by the 
working group is highly similar to that described in earlier publications 
(Petersen, 2004; Winblad et al., 2004). Core clinical criteria for the diagnosis 
of MCI due to AD are (i) concern by the patient, a close informant, or a skilled 
clinician regarding a change in cognition, (ii) impairment in at least one 
cognitive domain (memory, executive function, attention, language, 
visuospatial skills), (iii) maintained independence in daily life with only minimal 
aids or assistance, and (iv) no significant impairment in social or occupational 
functioning (Albert et al., 2011). Episodic memory is the most commonly 
affected in individuals with MCI who progress to dementia due to AD. In a 
neuropsychological assessment, cognitive impairment typically implies a 
deviation from age and education matched norms of at least 1 to 1.5 standard 
deviations.  
 In the second study of the present work, diagnosis of MCI was made 
on the basis of the highly similar criteria published by Winblad et al. (2004), 
requiring (i) classification as not normal, not demented, (ii) largely preserved 
activities of daily living, and (iii) evidence of cognitive decline measured in one 
of two ways, the first being report by self or informant and deficits on objective 
cognitive tasks, the second being decline over time in objective 
neuropsychological tasks. 
 
 Dementia due to AD 
 Core clinical criteria for dementia, irrespective of its cause, are 
cognitive or behavioral symptoms that interfere with everyday functioning, 
constitute a decline from previous levels of functioning, and are not explained 
by delirium or major psychiatric disorder (McKhann et al., 2011). In addition, 
cognitive impairment is diagnosed by combining information about patient 
history from the patient and a knowledgeable informant with an objective 
cognitive assessment. The neuropsychiatric symptoms involve two or more 
domains out of the following: acquiring and remembering new information; 
reasoning, handling of complex tasks, judgment; visuospatial abilities; 
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language, including speaking, reading, and writing; and personality, behavior, 
or comportment.  
 To assume that dementia diagnosed in a specific individual is caused 
by AD, additional criteria have to be met in order to assign a diagnosis of 
probable AD dementia, possible AD dementia, or  probable or possible AD 
dementia with evidence of the AD pathophysiologial process. The first and 
second term are intended for all clinical settings, while the third is intended for 
research settings. 
 The additional criteria for a diagnosis of probable AD dementia outlined 
by the NIA-AA working group are (i) gradual onset over months or years, (ii) 
clear history of cognitive decline established by report or observation, (iii) 
deficits in at least two cognitive domains evident on history and examination, 
and (iv) absence of substantial cerebrovascular disease, core features of 
dementia with Lewy bodies other than dementia, prominent features of 
behavioral variant frontotemporal dementia, semantic variant primary 
progressive aphasia or nonfluent/agrammatic variant primary progressive 
aphasia, and any other active neurological disease or non-neurological 
comorbidity as well as use of medication substantially affecting cognition. The 
level of certainty for this diagnosis is increased by documented cognitive 
decline based on cognitive testing and information from informants, and by 
evidence of a causative genetic mutation in APP, PSEN1, or PSEN2. 
 Criteria for possible AD dementia are an atypical course, with sudden 
onset of cognitive decline or insufficient documentation of decline progression, 
or mixed etiology, with concomitant (i) cerebrovascular disease, (ii) additional 
features of Lewy body dementia, (iii) medical comorbidity or medication use 
with a potentially substantial effect on cognition. 
 The diagnosis of probable AD dementia with evidence of the AD 
pathophysiological process is characterized by increased certainty about the 
postulated underlying cause of the clinical diagnosis of dementia syndrome. 
This increase in certainty stems from the use of biomarkers of Aβ deposition 
in the brain, measured by PET amyloid imaging, and cerebrospinal fluid (CSF) 
Aβ42, as well as elevated total and phosphorylated tau levels in the CSF, low 
tracer uptake during FDG PET in temporo-parietal cortex, and high atrophy on 




 The diagnosis of possible AD dementia with evidence of the AD 
pathophysiological process is based on the presence of non-AD dementia and 
biomarker evidence of AD pathophysiological process or fulfilled 
neuropathological criteria for AD. 
 
1.3 Early predictors of AD progression 
 PET, MRI, and CSF biomarkers can increase the certainty in the 
attribution of a dementia syndrome to AD, but they also have predictive value 
for AD progression in nondemented individuals (Jack et al., 2013). In a model 
proposed by an NIA-AA international workgroup (Sperling, Aisen, et al., 
2011),  these biomarkers become abnormal in an ordered sequence: First, 
biomarkers of Aβ accumulation, including amyloid PET imaging and CSF 
Aβ42, become abnormal. Second, biomarkers of synaptic dysfunction, 
including FDG PET and fMRI, become abnormal. Third, structural MRI 
becomes abnormal.  
 Levels of CSF Aβ42 have been shown to correspond to those of brain 
amyloid imaging by Pittsburgh compound B (PiB) PET and their relation to 
CSF tau levels predicted conversion from a Clinical Dementia Rating (CDR) 
(Morris, 1993) of 0 to a greater score (Fagan et al., 2007). This ratio of CSF 
tau, which is thought to be a marker of neurodegeneration and synaptic 
dysfunction together with FDG PET and MRI (Counts et al., 2017; 
Trojanowski et al., 2010), to CSF Aβ42 has also been shown to predict 
progression from MCI to AD (Trojanowski et al., 2010). At the MCI stage, CSF 
Aβ42, total tau, and threonine 181 phospho-tau each achieved good accuracy 
at identifying incipient AD (Mattsson et al., 2009). The ability of FDG PET 
(Drzezga et al., 2005; Mosconi et al., 2004) and hippocampal volume 
measured by structural MRI (Devanand et al., 2007; Grundman et al., 2002) 
to discriminate between subjects with MCI and AD dementia and predict 
conversion from MCI to AD has also been demonstrated. 
 However, the NIA-AA workgroup acknowledged that AD etiology is still 
uncertain and several researchers emphasized how amyloid-independent 
factors can lead to dementia in AD and may play an earlier or more central 
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role in its pathogenesis than Aβ (Herrup, 2010; Pimplikar, Nixon, Robakis, 
Shen, & Tsai, 2010). They also acknowledge that some individuals display all 
AD neuropathological features at autopsy but never showed dementia in their 
lifetime, and that it is unclear whether a best combination of biomarkers for 
prediction of clinical symptoms exists. Hence, research on preclinical AD 
biomarkers using different imaging modalities, novel analysis methods and 
refined measures is warranted in the search for optimal prediction of AD 
progression.  
 
1.4 The role of structural MRI for prediction of AD progression 
 As a consequence of the need to initiate treatment in the 
presymptomatic phase of AD, preventive screening of a large number of 
cognitively normal elderly individuals would be necessary. Thus, the 
instruments necessary for diagnostic measurement of suitable biomarkers 
would optimally be widely available and non-invasive. MRI measures 
identifying presymptomatic brain changes indicative of Aβ pathology would be 
a viable option in this regard. Structural MRI for volumetric and morphometric 
analysis of the hippocampus is routinely used in AD research and has been 
repeatedly shown to predict progression from MCI to AD dementia (G. 
Chételat et al., 2005; Tapiola et al., 2008) with greater atrophy in cognitively 
unimpaired subjects with future cognitive symptoms than subjects who 
remained cognitively healthy (Tondelli et al., 2012a). Hippocampal atrophy 
has been proposed as a possible marker of incipient AD in MCI (Dubois et al., 
2007; Frisoni, Fox, Jack, Scheltens, & Thompson, 2010). Although 
hippocampal atrophy is closely related to cognitive impairment, this 
established biomarker becomes abnormal relatively late according to current 
models of AD progression biomarkers (Counts et al., 2017; Jack et al., 2013). 
Hence, several investigations have focused on more localized measures of 
hippocampal atrophy, examining hippocampal subfields separately (Kerchner 
et al., 2010a) or detecting spatially confined changes with 3D maps 
(Apostolova et al., 2010). These localized structural MRI measures are 
potential presymptomatic AD biomarkers: Cognitively normal individuals who 
later developed aMCI and AD showed greater CA1 and subiculum atrophy 
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than stable cognitively normal individuals (Apostolova et al., 2010), and 
localized inward changes in left hippocampal surface predicted progression of 
non-demented elderly individuals to dementia due to AD (Csernansky et al., 
2005). 
 
1.5 The role of functional MRI for prediction of AD progression 
 Investigations of the potential of resting-state functional MRI (rsfMRI) 
for early detection of AD have shown promising results and rsfMRI is 
discussed as a biomarker preceding Aβ biomarkers (Jack et al., 2013). In 
autosomal dominant AD, default-mode network (DMN) functional connectivity 
has been found to decrease with increasing CDR and to be lower in 
asymptomatic mutation carriers that noncarriers with prominent involvement 
of the posterior cingulate cortex (PCC) (Chhatwal et al., 2013), suggesting 
alterations in this functional network already at the preclinical stage. An earlier 
study using task-related fMRI showed that PCC activity during a sensory-
motor processing task was decreased in individuals with mild AD compared to 
age-matched elderly controls (Greicius, Srivastava, Reiss, & Menon, 2004), 
suggesting that DMN functional connectivity may also be an early AD 
biomarker in late-onset AD. Connectivity changes in multiple resting state 
networks were similar in autosomal dominant and late-onset AD in a 
longitudinal rsfMRI study, and functional connectivity decreased with 
increasing CDR in both groups (Thomas et al., 2014). Using the PCC as seed 
region, a multi-center study revealed decreased functional connectivity with 
other DMN regions in each of the four dementia centers and in the pooled 
sample for individuals with MCI or AD compared to healthy controls (Wohlert 
et al., 2016).  
 Whereas these results are promising, research into functional 
connectivity of resting state networks as early AD biomarkers to date has 
been relatively scarce. Hence, replication of the published results is a crucial 
future step for this line of research. Methodological considerations play a 
pivotal role in the search for a stable, reliable biomarker derived from rsfMRI. 
In a recent evaluation of a previous multi-center study by their group (Wohlert 
et al., 2016), a team of researchers concluded that rsfMRI acquisition at 
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multiple centers limits its use in the diagnosis of MCI and AD (Teipel et al., 
2017), concluding that multiscanner variability is an important confound of 
group differences. There are also confounds of connectivity measured by 
rsfMRI at the individual study level, related to study design. Participants are 
instructed to lie still and keep their eyes closed, open, or fixated on a cross in 
front of them during scanning, depending on the study site. This slight 
variation in study design has been shown to influence reliability and 
consistency of connectivity patterns (R. Patriat, Molloy EK, et al., 2013) and to 
lead to differences in DMN connectivity (Yan et al., 2009). Hence, resting 
state network connectivity is a promising candidate in the search for 
presymptomatic AD biomarkers, but determining which aspects of study 
design have a notable influence on rsfMRI measures will play a crucial role in 
future research.  
2 Methods 
 
2.1 PET acquisition 
 PiB, the tracer used for amyloid imaging in the first study of the present 
work, was synthesized in an on-site cyclotron (16.5 MeV, GE). A detailed 
describtion of the sequence of reactions for [11C]-methyl triflate production is 
available elsewhere (Gietl et al., 2015). Tracer preparation was conducted 
based on the published procedure for radiolabeling (Solbach, Uebele, Reischl, 
& Machulla, 2005). Each participant received an antecubital venous injection 
of approximately 350 MBq of PiB. Data acquisition was performed during 70 
minutes (4 × 15, 8 × 30, 9 × 60, 2 × 180 and 10 × 300 s). 
 
2.2 MRI acquisition 
 MRI was acquired on a 3T Philips Achieva scanner  for the first study 
and on a 1.5T Philips Achieva scanner for the other two studies.  
 T1-weighted data in the first study were acquired with the following 
parameters: repetition time 8.2 ms, echo time 3.7 ms and 8° flip angle, field of 
view 240 mm (AP) × 220 mm (FH) × 188 mm (RL), 220 axial slices with 1-mm 
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single-slice thickness (voxel dimensions: 0.94 × 0.94 × 1 mm). T1-weighted 
data in the second study were acquired with the following parameters: 166 
slices, repetition time: 6.9 ms, echo time: 3.2 ms, flip angle: 8°, field of view: 
240 × 240 × 166 mm (anterior-posterior, foot-head, right-left), slice thickness: 
1 mm, total scan time: 15 min. T1-weighted data in the third study were 
acquired using an inversion recovery turbo field echo sequence with the 
following parameters: time of repetition = 6.9 ms, time of echo = 3.1 ms, flip 
angle = 8°, field of view = 240 mm, 400 x 400 scan matrix, slice thickness 1.2 
mm, 166 slices,  voxel size 0.6 x 0.6 mm) 
 In the third study, fMRI was done using echo-planar imaging and 
SENSE (sensitivity encoding for fast MRI (Pruessmann, Weiger, Scheidegger, 
& Boesiger, 1999))  with the following parameters: time of repetition = 3s, time 
of echo = 50 ms, flip angle = 90°, field of view = 220 mm, 128 x 128 scan 
matrix, slice thickness 3 mm, 34 slices, voxel size 1.72 x 1.72 mm. was 
acquired after the rs-fMRI scan. 
 
2.3 Automated segmentation of brain structures 
 Whereas manual delineation is sometimes described as the gold 
standard for image segmentation, this approach requires a prohibitive amount 
of time in large datasets (Pipitone et al., 2014) and is vulnerable to variability 
within and between expert human raters (Chakravarty et al., 2009; Shattuck et 
al., 2008). Hence, segmentation of the hippocampus and subcortical 
structures in the first and second study was performed by using the Multiple 
Automatically Generated Templates (MAGeT Brain) algorithm, which 
performs registration of multiple input atlases to a template library consisting 
of a representative sample of all target images, which in turn is used as the 
basis of target image labelling (Chakravarty et al., 2013). This results in a 
large number of labels for the segmented voxels in each target image, 
requiring a method to fuse them into one final label per segmented voxel. The 
value of MAGet Brain segmentation of the hippocampus and hippocampal 
subfields has been assessed in a series of experiments by the Computational 
Brain Anatomy Laboratory (CoBrA Lab) at the Douglas Mental Health 
University Institute (Verdun, QC, Canada; affiliated with McGill University) 
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(Pipitone et al., 2014). In an experimental evaluation of three different fusion 
methods: voxel-wise majority vote (Collins & Pruessner, 2010), cross-
correlation weighted majority vote (Aljabar, Heckemann, Hammers, Hajnal, & 
Rueckert, 2009), and normalized mutual information weighted majority vote 
(Studholme, Hill, & Hawkes, 1999), their performance did not significantly 
differ and the voxel-wise majority voting procedure was used in the remainder 
of the experiments (Pipitone et al., 2014) as well as in subsequent research 
(Amaral, Park, Devenyi, Lynn, Pipitone, Winterburn, Chavez, Schira, 
Lobaugh, Voineskos, et al., 2016; Chakravarty et al., 2015; Raznahan et al., 
2014). The five input atlases used for hippocampal subfield segmentation 
were produced on the basis of high-resolution T1 and T2 images acquired on 
a 3T scanner and had final super-sampled isotropic voxel dimensions of 
0.3mm (Winterburn et al., 2013). The input atlas used for thalamus and 
striatum segmentation was produced on the basis of histological data 
(Chakravarty, Bertrand, Hodge, Sadikot, & Collins, 2006). 
 
2.4 Shape and surface area calculation 
 Calculation of shape and surface area measures required 3D meshes 
of the structures of interest, which were constructed using the Marching 
Cubes algorithm (Lerch, Carroll, et al., 2008), and used the multiple nonlinear 
subject-to-atlas deformation fields. For better precision and accuracy and to 
limit the influence of noise and error, the nonlinear portions of the 
transformations from each subject to all templates were concatenated and 
averaged across the template library (Borghammer et al., 2010; Dorr, Lerch, 
Spring, Kabani, & Henkelman, 2008; Frey et al., 2011). Displacement in 
millimeters was then established at each vertex of the 3D mesh by calculating 
the dot product of the surface normal and the nonlinear deformation vector. 
Surface area was calculated by assigning to each vertex a third of the area of 





2.5 Cortical thickness calculation 
 Like measures of shape and surface area, cortical thickness is a 
vertex-wise parameter allowing for the detection of localized changes. In the 
present work, CT was calculated with the CIVET pipeline (version 1.1.10, 
Montreal Neurological Institute at McGill University, Montreal, Quebec, 
Canada) (Ad-Dab’bagh et al., 2006). In this pipeline, data are analyzed in a 
common space. Hence, individual T1 data were linearly registered to the 
symmetric ICBM 152 template (Collins, Neelin, Peters, & Evans, 1994; 
Mazziotta, Toga, Evans, Fox, & Lancaster, 1995) before skull stripping (Smith, 
2002) and tissue segmentation into gray and white matter and CSF (Tohka, 
Zijdenbos, & Evans, 2004; Zijdenbos, Forghani, & Evans, 1998). After these 
initial steps, the pipeline used deformable models that make use of a partial 
volume classification (Kim et al., 2005) for reconstruction of the inner and 
outer surfaces of the cortex before applying a method described in detail 
elsewhere (Lerch & Evans, 2005) to measure the distance in millimeters 
between corresponding vertices. To increase statistical power and signal-to-
noise ratio, blurring was performed on the cortical thickness maps with a 20 
mm diffusion smoothing kernel (Chung & Taylor, 2004). 
 
2.6 Resting state fMRI 
 Resting state data were analyzed using the functional connectivity 
toolbox CONN (version 14h; http://www.nitrc.org/projects/conn/) and the 
Group ICA of fMRI Toolbox (GIFT; version 3.0a; 
http://mialab.mrn.org/software/gift/). In CONN, Pre-processing steps included 
realignment, temporal filtering (0.01 – 0.1 Hz, Biswal, Yetkin, Haughton, and 
Hyde (1995)), detrending, slice-timing correction, coregistration, 
segmentation, normalisation, spatial smoothing (8 mm) and anatomical 
component-based noise correction (aCompCor) method (Behzadi, Restom, 
Liau, & Liu, 2007) to correct for physiological noise, which outperforms global 
signal correction (Chai, Castanon, Ongur, & Whitfield-Gabrieli, 2012) and 
increases the validity of ensuing analyses (Whitfield-Gabrieli & Nieto-
Castanon, 2012). In the present work, analysis was applied on spherical 
regions of interest (ROI) predefined by CONN using Talairach Daemon 
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(http://www.talairach.org/daemon.html) labels. In GIFT, principal component 
analysis was run on the dataset of each subject before group ICA, which 
resulted in 20 independent components estimated by the infomax algorithm 
(Bell & Sejnowski, 1995). Group ICA was run both using the entire sample, for 
significance testing of group differences in non-artefact (neuronal) 
components, and separately for the experimental and control groups in order 
to assess correspondence of components between the two groups. MRIcron 
(http://www.nitrc.org/projects/mricron) was used to discern artefactual from 
neuronal components and to identify RSNs. The ICASSO toolbox 
(research.ics.aalto.fi/ica/icasso) was used to run the infomax algorithm 20 
times for reliability assessment, starting with different initial values and using a 
bootstrap technique (minimal cluster size 16, maximal cluster size 20).  
 
3 Aims, research questions, and hypotheses 
 The main aims of the present work were to examine the potential of 
hippocampal, thalamic, and striatal shape and cortical thickness as 
biomarkers in preclinical AD and to investigate the influence of participant 
information on a promising candidate for prediction of AD progression in 
cognitively unimpaired elderly individuals: functional connectivity within and 
between RSNs measured using rsfMRI. 
 
3.1 Study 1 
 The research question of the first study was whether AD biomarker 
reserach using structural MRI data would profit from using localized measures 
of shape, surface area, subfield volumes and cortical thickness rather than 
volumes of entire structures. Different hippocampal (H. Braak & Braak, 
1991b), thalamic (Aggleton, Pralus, Nelson, & Hornberger, 2016; H. Braak & 
Braak, 1991a), and cortical (Dickerson et al., 2008; Dickerson et al., 2011) 
regions are affected sequentially by AD pathology and thus, our hypothesis 
was that already in cognitively unimpaired individuals, these localized 
measures would correlate with AD pathology. This hypothesis was tested in 
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cognitively unimpaired individuals by correlating hippocampal, thalamic, and 
striatal shape, SA, and volume with amyloid load of the respective region and 
of the neocortex measured by PiB PET. We also correlated hippocampal 
subfield volumes with hippocampal and neocortical amyloid load, and cortical 
tickness with neocortical amyloid load. 
 
3.2 Study 2 
 The research question of the second study was whether localized 
structural MRI measures differentiate between healthy elderly and MCI 
subgroups of individuals who later converted to AD dementia or remained 
stable. In this study, we measured volumes of the hippocampus and its 
subfields, the thalamus and its nuclei, the striatum, and the globus pallidus in 
addition to thalamic and striatal shape as well as cortical thickness. We 
compared converters at baseline and time of conversion and non-converters 
at baseline to their respective age and sex matched control group. We 
hypothesized that all three MCI groups would differ from matched controls, 
with more pronounced differences in converters. In addition, we conducted a 
receiver operating characteristic curve analysis to test the hypothesis that 
localized measures improve classification based solely on volume information.  
 
3.3 Study 3 
 The research question of the third study was whether RSN functional 
connectivity is affected by participant information. Several studies have found 
that this is the case for variation of participant instruction (R. Patriat, Molloy 
EK, et al., 2013; K. Van Dijk et al., 2010; Yan et al., 2009), hampering the 
comparison of findings across study sites and impeding generalizability and 
reproducibility of results from rsfMRI analyses. We hypothesized that 
participant information would also affect rsfMRI measures and investigated 
connectivity between individual regions of interest as well as within and 
between functional networks. To test this hypothesis, we compared two 
groups of elderly subjects and experimentally manipulated their information 
status during scanning.  
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4 Empirical evidence 
 
 4.1 Hippocampal shape alterations are associated with 
regional Aβ load in cognitively normal elderly individuals 
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 Abstract 
 Aβ deposition is a driving force of Alzheimer’s disease pathology and 
can be detected early by amyloid positron emission tomography. Identifying 
presymptomatic structural brain changes associated with Aβ deposition might 
lead to a better understanding of its consequences and provide early 
diagnostic information. In this respect we analyzed measures of cortical 
thickness and subcortical volumes along with hippocampal, thalamic and 
striatal shape and surface area by applying novel analysis strategies for 
structural magnetic resonance imaging. We included 69 cognitively normal 
elderly subjects after careful clinical and neuropsychological workup. 
Standardized uptake value ratios (cerebellar reference) for uptake of 11-C-
Pittsburgh Compound B (PiB) were calculated from positron emission 
tomographic data for a cortical measurement and for bilateral hippocampus, 
thalamus and striatum. Associations to shape, surface area, volume and 
cortical thickness were tested using regression models that included 
significant predictors as covariates. Left anterior hippocampal shape was 
associated with regional PiB uptake (p < 0.05, FDR-corrected), whereas 
volumes of the hippocampi and their subregions were not associated with the 
cortical measurement or uptake in the other regions (all p > 0.05, FDR-
corrected). Within the entorhinal cortical region of both hemispheres, 
thickness was negatively associated with cortical uptake (p < 0.05, FDR-
corrected). Hence, localized shape measures and cortical thickness may be 
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 Sporadic Alzheimer's disease (AD) is a major global health burden with 
no cure available at the moment. It has become evident that the pathological 
process may start decades before the onset of clinical symptoms (Villemagne 
et al., 2013). Therefore, diagnostic criteria have been developed to identify the 
preclinical stages of Alzheimer's disease (Sperling, Aisen, et al., 2011) with 
the ultimate goal of facilitating studies on early intervention. Currently, the A-4 
trial examines if the antibody solanezumab may be beneficial in cognitively 
asymptomatic subjects selected on the basis of a positive amyloid-pet (Laske, 
2014). It is hypothesized that intervention at presymptomatic stages is most 
effective treatment when cognitive functioning can be stabilized at the highest 
possible level (Masdeu et al., 2012). Furthermore, substances directed at 
Abeta-reduction are believed to be more effective if given early in the disease 
process. A scenario of early detection would require a high number of 
cognitively normal elderly individuals to undergo preventive screening. Hence, 
it is desirable to obtain diagnostic measures non-invasively and at 
comparatively low cost. In this respect, magnetic resonance imaging (MRI) 
measurements capable of identifying early brain changes associated with 
amyloid deposition would pose an attractive option. 
 Highly localized structural MRI measures such as cortical thickness 
(CT) and subcortical shape and surface area (SA) of brain structures are 
necessary to detect highly spatially confined presymptomatic changes. Using 
CT analysis, a recent study presented results that are consistent with cortical 
thinning during progression from preclinical AD to dementia due to AD 
(Dickerson et al., 2011). In addition, evidence for early thalamic abnormalities 
in Alzheimer's disease is growing (Aggleton et al., 2016). Previous studies 
have reported thalamic differences between normal-aging subjects and 
individuals with amnestic MCI using texture analysis (de Oliveira et al., 2011) 
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and smaller thalamic volume in MCI compared to controls with normal 
cognition (Yi et al., 2015). In a recent study from our group, we found thalamic 
and striatal shape differences between individuals with MCI and individuals 
with normal cognition in the absence of volumetric differences (Leh et al., 
2016). These findings suggest that thalamic shape changes occur early in AD 
and underline the importance of thalamic shape information in the search for 
presymptomatic AD biomarkers and point to an important role of the anterior 
thalamic nuclei in AD research which play an important role in episodic 
memory. In contrast to thalamic shape, hippocampal morphology has already 
been studied repeatedly in AD (de Flores, La Joie, & Chetelat, 2015) and 
studies comparing patients with AD to healthy control subjects have shown 
inward deformation of cornu ammonis (CA) 1 (Frisoni et al., 2008; Wang et 
al., 2003). In one previous study, localized inward changes in left hippocampal 
surface significantly predicted progression of non-demented elderly 
individuals to dementia due to AD (Csernansky et al., 2005). 
 In this study, we therefore used structural MRI measures of CT and 
hippocampal, thalamic and striatal volume, shape and SA to identify brain 
changes associated with amyloid deposition measured by Pittsburgh 
compound B (PiB) positron emission tomography (PET) in cognitively normal 
elderly individuals. 
 
 Materials and methods 
 
 Participants 
 A total of 69 cognitively healthy elderly participants (32 women, age 
55–80 years) from a longitudinal cohort study were included. Seventeen of 
these participants have already been included in a previous publication from 
our group focusing on structural differences between individuals with amnestic 
MCI and cognitively normal subjects (Leh et al., 2016). Inclusion and 
exclusion criteria have been published previously (Gietl et al., 2015; Schreiner 
et al., 2014; Steininger et al., 2014). Cognitive health was confirmed by 
clinical examination consisting of clinical workup and neuropsychological 
assessment and a Mini-Mental State Examination (MMSE) score of ≥27. 
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Participants were excluded if one or more of the following conditions were 
met: contraindication against MRI or venipuncture, substance abuse with a 
possible effect on cognition, change in red blood cell count of clinical 
significance, allergy to PiB or one of its constituents, history of severe allergic 
reactions to drugs or allergens, critical or medically unstable illness, 
pregnancy or lactation and significant exposure to radiation. 
 Descriptive data for all metric control, volume and standardized uptake 
value ratio (SUVR) variables can be found in Table 1. 
 
Table 1. Descriptive data for all control, volume and SUVR variables 
Variable M SD 
Age (years) 68.087 6.029 
Education (years) 15.101 2.739 
ICV (cubic centimeters) 1326.871 205.983 
Volume of left hippocampus* 17.446 2.467 
Volume of right hippocampus* 17.242 2.405 
Volume of left CA1* 5.471 0.733 
Volume of right CA1* 5.560 0.749 
Volume of left subiculum* 2.459 0.371 
Volume of right subiculum* 2.684 0.407 
Volume of left CA4/DG* 4.269 0.683 
Volume of right CA4/DG* 4.254 0.643 
Volume of left CA2/CA3* 1.162 0.211 
Volume of right CA2/CA3* 1.074 0.236 
Volume of left SRLM* 4.086 0.649 
Volume of right SRLM* 3.669 0.603 
Cortical SUVR 1.245 0.275 
SUVR of left hippocampus 1.238 0.106 
SUVR of right hippocampus 1.235 0.098 
SUVR of left thalamus 1.425 0.193 
SUVR of right thalamus 1.404 0.176 
SUVR of left striatum 1.342 0.256 
SUVR of right striatum 1.343 0.252 
M, mean; SD, standard deviation; ICV, intracranial volume; CA, cornu 
ammonis; DG, dentate gyrus; SRLM, strata radiata/lacunosum-moleculare; 
SUVR, standardized uptake value ratio. 




 This study was conducted in compliance with the Helsinki Declaration 
and approved by the cantonal ethics committee of Zurich, Switzerland 
(E_64_2009). Written informed consent was obtained from each participant 
prior to study enrolment. 
 
 PET acquisition 
 The PET acquisition procedure has been previously published (Gietl et 
al., 2015; Schreiner et al., 2014; Steininger et al., 2014). Each participant 
received an antecubital venous injection of approximately 350 MBq of PiB 
(PiB synthesis has been described before in Gietl et al., 2015). A 70-min 
dynamic PET scan (4 × 15, 8 × 30, 9 × 60, 2 × 180 and 10 × 300 s) was 
performed. Voxel spacing was 2.34 × 2.34 × 3.27 mm. 
 
 MR acquisition 
 MR acquisition has been published previously (Gietl et al., 2015). T1-
weighted data were acquired on a 3-T Phillips Achieva with the following 
parameters: repetition time 8.2 ms, echo time 3.7 ms and 8° flip angle, field of 
view 240 mm (AP) × 220 mm (FH) × 188 mm (RL), 220 axial slices with 1-mm 
single-slice thickness (voxel dimensions: 0.94 × 0.94 × 1 mm). 
Subcortical segmentation and volume calculation 
 Segmentation of bilateral hippocampus, thalamus and striatum as well 
as hippocampal subfields was performed by using the Multiple Automatically 
Generated Templates (MAGeT Brain) algorithm (Chakravarty et al., 2013)  
using a voxel-wise majority vote (Collins & Pruessner, 2010). The input 
atlases used for hippocampal subfield segmentation were produced by 
Winterburn et al. (Winterburn et al., 2013) and have been validated for use 
with MAGeT brain (Pipitone et al., 2014). The five subfields delineated in 
these atlases are cornu ammonis (CA) 1, subiculum, CA 4 and dentate gyrus, 
CA 2 and 3 and stratum radiatum/lacunosum/moleculare (SRLM). We used 
five input atlases that were registered to a subset of 21 subjects, a number 
that had been shown to be optimal in previous research (Pipitone et al., 
2014), to generate a template library. The input atlas used for thalamus and 
striatum segmentation was produced by Chakravarty, Bertrand, Hodge, 
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Sadikot, & Collins(Chakravarty et al., 2006). A visualization of the left-
hemispheric part of these volumes of interest is displayed in Fig. 1. 
 
Figure 1. Subcortical segmentation. 
 
 
Figure 1. Segmentation of the thalamus, the striatum and the five 
hippocampal subfields. Left-hemispheric structures are depicted. 
 
 For each subject, volumes of total hippocampi and their subfields were 
derived from the number of voxels resulting from segmentation. These 
volumes were then divided by the total intracranial volume of the subject and 
the resulting value was used for analysis. Calculation of total intracranial 
volume has been described previously (Buckner et al., 2004). 
 
 Determination of cortical 11-C-PiB-SUVR (cortical SUVR from now on) 
as a measure of cortical plaque burden 
 Image processing was done automatically under visual control with 
PMOD PNEURO tool Version 3.4 (PMOD LTD, Zurich, Switzerland) and 
described in detail before (Gietl et al., 2015). The average of the first 13 
frames of the dynamic scans was co-registered with the structural MR image 
using a normalized mutual-information–based registration. After 
normalization, a maximum probability atlas (Hammers N30R83) (Gousias et 
al., 2008; Hammers et al., 2003) was used to define 48 VOIs based on the 
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segmentation of GM and white matter. Segmentation was performed on the 
individual MRI (at least 50% GM probability). The combined transformation 
matrices (PET to MR and MR to Montreal Neurologic Institute [MNI] space) 
were applied to the dynamic PET images to perform all further analyses in 
MNI space. The average tracer uptake 50–70 min was then calculated for the 
segmented grey matter VOIs. For derivation of cortical SUVR, 24 bilateral 
cortical brain structures of the Hammers N30R83 atlas 
(http://doc.pmod.com/pneuro/7674.htm) – excluding occipital lobe, insula, 
primary motor and sensorimotor cortices – were merged using a volume-
weighted averaging procedure, ascertaining that the uptake in larger regions 
contributes more to this average than the uptake in smaller regions. Bilateral 
cerebellar grey matter uptake, which was also derived from the Hammers 
N30R83 atlas, served as a reference for standardization between subjects 
because of the relatively late involvement of the cerebellar grey matter in 
plaque pathology, as done before (Johnson et al., 2016; Liu et al., 2015). The 
ratio of the cortical VOI's average uptake and the average cerebellar grey 
matter uptake is termed “cortical SUVR” and serves as a measure of cortical 
plaque burden. 
 
 Regional 11-C-PIB-SUVR (regional SUVR from now on) calculation 
 Image processing for regional SUVR calculation was done with PMOD 
FUSION tool Version 3.5 (PMOD LTD, Zurich, Switzerland). Also in this 
analysis the average of the first 13 frames was co-registered with the 
structural MR image using a normalized mutual-information–based 
registration. Registration success was determined by visual inspection 
performed by our group. The regions specifically studied for shape changes 
within this project for hippocampal, thalamic and striatal SUVR calculation 
were derived from automatic subcortical segmentation with the MAGeT Brain 
algorithm as described above. This algorithm has been demonstrated to 
outperform FreeSurfer and FSL FIRST (Pipitone et al., 2014). Segmentation 
was performed in subject space of the individual MR. The PET to MR 
transformation matrices from the registration process were applied to the 
dynamic PET images to be able to place the MR-derived regions on the PET 
image. Subsequent analyses were performed in subjects’ MR space. Again, 
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the average tracer uptake 50–70 min was then calculated for the segmented 
VOIs. The cerebellar reference region used for calculation of regional SUVR 
was segmented using the LONI probabilistic brain atlas (LPBA40) (Shattuck 
et al., 2008). The ratio of the specific uptake of a particular VOI and the 
cerebellar grey matter uptake is termed “regional SUVR”. 
 
 Shape and SA calculation 
 Delineation of bilateral hippocampus, thalamus and striatum was 
carried out using a method adapted from Lerch et al. (Lerch, Carroll, et al., 
2008) to measure local inward and outward displacements. For a detailed 
description, see Lerch et al. (Lerch, Carroll, et al., 2008) and Raznahan et al. 
(Raznahan et al., 2014). SA calculation was performed as described 
previously (Raznahan et al., 2014). 
 
 Cortical thickness calculation 
 CT was calculated with the CIVET pipeline (version 1.1.10, Montreal 
Neurological Institute at McGill University, Montreal, Quebec, Canada) (Ad-
Dab’bagh et al., 2006). First, the T1 image of each subject was linearly 
registered to the symmetric ICBM 152 template (Collins et al., 1994; Mazziotta 
et al., 1995). Then, skull stripping (Smith, 2002) and tissue segmentation into 
gray and white matter and cerebrospinal fluid (CSF) (Tohka et al., 2004; 
Zijdenbos et al., 1998) were carried out. Next, the interface between gray 
matter and CSF and the inner white matter surface were constructed for each 
hemisphere using deformable models (Kim et al., 2005). For each of the 
resulting 40 962 vertices per hemisphere, the distance in millimeters between 
the inner and the outer surface was measured using a previously described 
method (Lerch & Evans, 2005). To increase statistical power and signal-to-
noise ratio, blurring was performed on the cortical thickness maps with a 20-
mm diffusion smoothing kernel (Chung & Taylor, 2004). 
 
 Data analysis 
 For statistical analysis, the R software package (https://www.r-
project.org/) (R Core Team, 2014) was used. In addition, the RMINC (R for 
Medical Imaging NetCDF) library 
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(https://wiki.mouseimaging.ca/display/MICePub/RMINC/) (Lerch & Nikelski, 
2009) was used for statistical analysis of the associations between 
shape/SA/CT and cortical/regional SUVR. 
 To specify the most adequate model in each regression analysis, the 
following procedure was performed: First, the relevance of each of the 
following potential covariates was assessed by using the covariate and 
cortical or regional SUVR as regressors: age (in years), gender, education (in 
years), total intracranial volume and APOE genotype. Second, a regression 
model was specified retaining only the significant covariates as regressors. 
Models testing associations between volumes and SUVR did not include total 
intracranial volume as a covariate because these volumes were normalized 
by total intracranial volume. In this sample, education and APOE genotype did 
not significantly predict hippocampal volume, thalamic volume, striatal 
volume, shape or CT. 
 
 Associations between volumes and SUVR 
 All volumes were adjusted for total intracranial volume using a method 
described previously (Buckner et al., 2004). To investigate the associations 
between SUVR and hippocampal total and subfield volumes as well as 
thalamic and striatal volumes, regression models were specified with volume 
as regressand and cortical or regional SUVR as regressor. First, these 32 
models were specified including age, gender, education and APOE genotype 
as covariates. In these 32 models, education was never a significant 
covariate, APOE genotype was significant three times, age 24 times and 
gender 28 times. Therefore, regression models using age and gender as 
covariates were specified to investigate the associations between SUVR and 
volumes. The resulting P-values were Benjamini-Hochberg FDR corrected for 
multiple comparisons with number of comparisons m set to 12, taking into 
consideration the high dependency of hippocampal subfield volumes from 
each other and total hippocampal volume. 
 
 Associations between shapes or SA and SUVR 
 To investigate the association between shapes and cortical or regional 
SUVR, a regression model was specified at each vertex with displacement as 
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regressand and cortical or regional SUVR as regressor. First, these 12 
models were specified including age, gender, education, total intracranial 
volume and APOE genotype as covariates. In these 12 models, age, 
education and APOE genotype were never significant covariates, total 
intracranial volume was significant 8 times and gender 12 times. Therefore, 
regression models using gender and total intracranial volume as covariates 
were specified to investigate the associations between SUVR and shapes. In 
each of these cases, the resulting test statistics were FDR corrected for 
multiple comparisons (Benjamini-Hochberg). FDR-corrected values of P < 
0.05 were considered significant. 
 To investigate the association between SA and cortical or regional 
SUVR, a regression model was specified at each vertex with SA as 
regressand and cortical or regional SUVR as regressor. First, these 12 
models were specified including age, gender, education, total intracranial 
volume and APOE genotype as covariates. In these 12 models, APOE 
genotype was never a significant covariate, education was significant once, 
gender was significant 5 times, age 8 times and total intracranial volume 12 
times. Therefore, regression models using gender, age and total intracranial 
volume as covariates were specified to investigate the associations between 
SUVR and SA. In each of these cases, the resulting test statistics were FDR 
corrected for multiple comparisons (Benjamini-Hochberg). FDR-corrected 
values of P < 0.05 were considered significant. 
 
 Associations between CT and cortical SUVR 
 To investigate the association between CT of each hemisphere and 
cortical SUVR, a regression model was specified at each vertex with CT as 
regressand and cortical SUVR as regressor. First, these two models were 
specified including age, gender, education, total intracranial volume and 
APOE genotype as covariates. In both models, age and total intracranial 
volume were significant covariates. Therefore, regression models using age 
and total intracranial volume as covariates were specified to investigate the 
associations between cortical SUVR and CT. Again, the resulting test 
statistics were FDR corrected for multiple comparisons (Benjamini-Hochberg). 
FDR-corrected values of P < 0.05 were considered significant. To determine 
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the cortical regions wherein significant associations occurred, two separate 
atlases were used (Amunts et al., 2005; Mai, Majtanik, & Paxinos, 2015). 
 
 Associations between cognitive performance and SUVR or volume 
 To confirm that cortical/regional SUVR and volume were not 
associated with cognitive performance in our sample of cognitively normal 
elderly subjects, regression models were specified for nine measures 
pertaining to memory and executive function (Table 2). For memory 
assessment, the German-language verbal learning and memory test “Verbaler 
Lern- und Merkfähigkeitstest” (VLMT) was used, providing learning, recall and 
recognition measures of verbal memory (Helmstaedter, Lendt, & Lux, 2001; 
Volz-Sidiropoulou, Poll, Forkmann, & Gauggel, 2010), as well as digit span 
forward from the Wechsler Memory Scale - Revised (Härting et al., 2000). For 
assessment of executive function, the following neuropsychological measures 
were obtained: Digit span backward from the Wechsler Memory Scale – 
Revised (Härting et al., 2000), verbal (semantic) fluency and letter (phonemic) 
fluency from the CERAD-plus test battery (Thalmann et al., 1997), the five-
point test (5PT) (Kelemen & Fenton, 2010; Regard, Strauss, & Knapp, 1982) 
and a measure from the trail making test (TMT) (Reitan, 1958) calculated by 
dividing the result of its B version by the result of its A version, which 








 Associations between volumes and SUVR 
 Descriptive data for volumes and SUVR are shown in Table 1. 
Volumes of bilateral hippocampus and hippocampal subfields CA4/DG, 
CA2/CA3 and SRLM, left hippocampal subiculum and CA1 subfields as well 
as right thalamus were associated with cortical SUVR but not with regional 
SUVR (see Table 3). 
 
 Associations between shapes or SA and SUVR 
 Significant associations were found between left thalamic shape 
outward deformations and cortical SUVR in the region of its anterior nuclei 
(Fig. 2A), as well as between left thalamic SA and regional SUVR in the area 
of its pulvinar (Fig. 2B). In addition, significant associations were found 
between left anterior hippocampal shape and regional SUVR, predominantly 
in its CA1 and subiculum regions, with dorsal outward and ventral inward 
deformations, respectively (Fig. 2C). 
 
 Associations between CT and cortical SUVR 
 Significant negative associations between CT and SUVR were found 
for the left and right hemisphere. The areas of these associations 
corresponded highly between the hemispheres and occurred within the 
entorhinal cortex (EC) region (Fig. 3). 
 
 Associations between cognitive performance and SUVR or volumes 
 Descriptive data for measures of cognitive performance are shown in 
Table 2. No associations between cognitive performance and SUVR (Table 4) 








Figure 2. Associations between shapes or SA and SUVR 
 
 
Figure 2. (A) Colored areas show significant associations between thalamic 
shape and cortical SUVR using a FDR-corrected P value of 0.05. Scatterplots 
on the right-hand side illustrate dispersion of values at peak vertices (minimal 
and maximal t value). Dorsal view of bilateral thalamus shows associations 
between outward deformations and cortical SUVR in the area of the left 
anterior dorsal nuclei. (B) Colored areas show significant associations 
between thalamic SA and regional SUVR using a FDR-corrected P value of 
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0.05. This posterior view of bilateral thalamus shows negative associations 
between SA and regional SUVR in the area of the left mediodorsal nucleus. 
Scatterplot on the right-hand side illustrates dispersion of values at the peak 
vertex (minimal t value). (C) Colored areas show significant associations 
between hippocampal shape and regional SUVR using a FDR-corrected P 
value of 0.05. Scatterplots on the right-hand side illustrate dispersion of 
values at peak vertices (minimal and maximal t value). Upper row: Dorsal 
view of bilateral hippocampus shows associations between outward 
deformations and regional SUVR in the area of the left anterior hippocampus. 
Lower row: Ventral view of bilateral hippocampus shows associations 
between inward deformations and regional SUVR. L, left; R, right; A, anterior; 




Figure 3. Associations between CT and cortical SUVR 
 
  
Figure 3. Upper row: Colored areas show significant associations between CT 
and cortical SUVR using a FDR-corrected P value of 0.05. This medial view of 
both hemispheres shows negative associations between CT and cortical 
SUVR in the area of bilateral EC. Lower row: Scatterplots illustrate dispersion 




















































































































 The goal of this study was to investigate structural brain changes in 
cognitively healthy elderly subjects with various degrees of cerebral amyloid 
deposition. We showed that bilateral hippocampal volumes were not 
significantly associated with regional SUVR in healthy subjects, extending 
findings from a study of patients with mild AD (Y. T. Chang et al., 2015). In 
contrast to our findings, previous studies showed that hippocampal volumes 
were related to cortical PiB uptake in healthy elderly subjects (Hsu et al., 
2015; Mormino et al., 2008), and a recent study using PiB PET and CSF tau 
and ptau to classify participants into stages of preclinical AD found smaller 
hippocampal volumes in later preclinical stages (Gordon et al., 2016). In 
addition, hippocampal atrophy in CA1 and the subiculum has been shown to 
predict progression to amnestic MCI in cognitively normal elderly individuals 
(Apostolova et al., 2010; Kerchner et al., 2010a). Here, our findings would be 
consistent with the assumption that Aβ deposition precedes hippocampal 
atrophy (Jack et al., 2013; Mormino et al., 2008). With respect to the staging 
model of preclinical Alzheimer's disease (Sperling, Aisen, et al., 2011), it 
could be that our population represents a very early stage with predominantly 
amyloid deposition without concomitant hippocampal atrophy. Left 
hippocampal shape was not significantly associated with cortical, but with 
regional SUVR. These findings suggest that early hippocampal shape 
changes may reflect a localized reaction to amyloid deposition. Hippocampal 
shape has been shown to be associated with Aβ measured in CSF in healthy 
elderly individuals in a previous study (Carmichael et al., 2012). This study 
derived shape measures from independent component analysis, where 
components defined a subregion of the three-dimensional hippocampus 
representation. In contrast, vertex-wise displacement values were used in this 
study. Whereas CSF Aβ allows a global estimation of cerebral amyloid 
deposition, by using amyloid-PET we were able to separately analyze cortical 
and regional SUVR in this study. Hence, the present results are more 
informative with regard to the localization of significant associations between 
hippocampal shape and SUVR and they extended the previous findings by 
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showing that hippocampal but not cortical Aβ load was associated with 
hippocampal shape. 
 The localization of these associations with left anterior CA 1 
corroborates previous findings in MCI patients (de Flores et al., 2015) and is 
in line with a previous study on progression of non-demented elderly 
individuals to dementia due to AD (Csernansky et al., 2005). This finding 
should be interpreted in the context of our results revealing entorhinal cortical 
thickness associations with cortical SUVR. The EC is affected early by tau 
pathology in AD (H. Braak & Braak, 1991b) and projects to the hippocampus 
via the perforant pathway, which is not only the primary input to the 
hippocampal formation but also originates from cells that show neurofibrillary 
tangles in AD (Hyman, Van Hoesen, Kromer, & Damasio, 1986). Adding 
amyloid deposits to the perforant pathway terminal zone of neurons 
containing pathological tau has recently been shown to increase the extent of 
dystrophic axons and strongly alter the connectivity of these neurons in a 
transgenic mouse model (Pooler et al., 2013). Thus, shape changes 
associated with amyloid deposition may represent axonal damage due to 
amyloid toxicity in entorhinal neurons containing pathological tau. 
Hippocampal SUVR has been shown to correlate with fluid attenuated 
inversion recovery intensities, indicating tissue edema, in cognitively normal 
elderly subjects (Schreiner et al., 2014), supporting the view that a 
degenerative process underlies the association between hippocampal SUVR 
and shape found in this study. 
 Furthermore, our analyses revealed significant associations between 
shape and cortical SUVR in the region of the anterior dorsal nuclei of the left 
thalamus. The anterior thalamic nuclei contain numerous neurofibrillary 
tangles in AD (H. Braak & Braak, 1991a) and are implicated in memory 
(Jankowski et al., 2013). They have been shown to receive inputs from the 
subiculum in rat and monkey (Aggleton, Desimone, & Mishkin, 1986; Wright, 
Erichsen, Vann, O'mara, & Aggleton, 2010), a hippocampus region that has 
been shown to be affected early by histopathological events in AD in mice 
(Trujillo-Estrada et al., 2014). In light of these findings, our results indicate that 
localized variations in left thalamic shape may reflect early changes in 
memory circuits preceding cognitive symptoms. The fact that left but not right 
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thalamic shape was associated with cortical SUVR is consistent with findings 
of asymmetrical brain changes in AD with left-hemispheric predominance 
(Thompson et al., 2003). 
 EC thickness was bilaterally associated with cortical SUVR consistent 
with an early involvement of the EC in the AD continuum. The EC is a region 
affected early by NFT pathology in AD (H. Braak & Braak, 1991b), and 
localized EC atrophy may accelerate up to 10 years before clinical symptom 
onset (Younes, Albert, Miller, & BIOCARD Research Team, 2014). Because 
of the low number of individuals with high cortical SUVR, it may be argued 
that these outliers cause an overestimation of the true associations with CT. 
However, their localization is in striking correspondence with a previously 
reported AD cortical thinning signature in asymptomatic individuals (Dickerson 
et al., 2008; Dickerson et al., 2011). 
 We found no association between SUVR or volumes and a number of 
cognitive performance measures, which is consistent with the notion that the 
earliest pathological changes in AD may occur 10–20 years before symptom 
onset (Laske, 2014) and in line with a recent publication reporting no 
significant difference between amyloid-positive and amyloid-negative 
cognitively normal elderly individuals in verbal, visual and semantic memory, 
executive function and processing speed (Besson et al., 2015). 
 One limitation of our study is the resolution of PET images, which 
prohibits more localized quantification of tracer uptake such as calculation of a 
separate SUVR for each hippocampal subregion. Another limitation might be 
that we decided within this healthy group to not apply partial volume 
correction which could affect the accuracy of quantitative PET analysis 
(Rullmann et al., 2016). Considering that we found no effect of volume on 
regional SUVR, we assume that there is no bias introduced by not applying a 
partial volume correction. Furthermore, the regions of interest analyses were 
focused on individually segmented and grey matter delined regions reducing 
the general effect of atrophy on regional averages. 
 In addition, future studies should incorporate longitudinal data from 
cognitively normal elderly subjects progressing to MCI and cognitively stable 
elderly subjects to obtain quantitative estimates of the predictive value of local 
deformations of medial temporal lobe structures with regard to cognitive 
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decline. Our CT results suggest that in addition to the hippocampus, the EC 
should be characterized in terms of shape using our methodology to compare 
the predictive value of changes in EC thickness with that of changes in EC 
shape. In conclusion, the results of this study suggest that structural brain 
changes occur in association with amyloid deposition in presymptomatic AD 
and that these changes are detectable by measures of hippocampal shape 
and entorhinal cortical thickness. This positions these measurements as 
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 Efficacy of future treatments depends on biomarkers identifying 
patients with mild cognitive impairment at highest risk for transitioning to 
Alzheimer's disease. Here, we applied recently developed analysis 
techniques to investigate cross-sectional differences in subcortical shape and 
volume alterations in patients with stable mild cognitive impairment (MCI) (n = 
23, age range 59–82, 47.8% female), future converters at baseline (n = 10, 
age range 66–84, 90% female) and at time of conversion (age range 68–87) 
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compared to group-wise age and gender matched healthy control subjects (n 
= 23, age range 61–81, 47.8% female; n = 10, age range 66–82, 80% female; 
n = 10, age range 68–82, 70% female). Additionally, we studied cortical 
thinning and global and local measures of hippocampal atrophy as known key 
imaging markers for Alzheimer's disease. Apart from bilateral striatal volume 
reductions, no morphometric alterations were found in cognitively stable 
patients. In contrast, we identified shape alterations in striatal and thalamic 
regions in future converters at baseline and at time of conversion. These 
shape alterations were paralleled by Alzheimer's disease like patterns of left 
hemispheric morphometric changes (cortical thinning in medial temporal 
regions, hippocampal total and subfield atrophy) in future converters at 
baseline with progression to similar right hemispheric alterations at time of 
conversion. Additionally, receiver operating characteristic curve analysis 
indicated that subcortical shape alterations may outperform hippocampal 
volume in identifying future converters at baseline. These results further 
confirm the key role of early cortical thinning and hippocampal atrophy in the 
early detection of Alzheimer's disease. But first and foremost, and by 
distinguishing future converters but not patients with stable cognitive abilities 
from cognitively normal subjects, our results support the value of early 
subcortical shape alterations and reduced hippocampal subfield volumes as 




 Recent findings have demonstrated that beta-amyloid can be 
effectively removed from the brain, which may have a beneficial effect on 
cognitive function (Sevigny, Chiao, Bussière, et al., 2016). Following the 
concept of the amyloid-hypothesis, Alzheimer's disease (AD) treatment 
methods that are currently under investigation may be most efficacious in 
preclinical or early disease stages (Golde, Schneider, & Koo, 2011; Sevigny, 
Chiao, Bussière, et al., 2016; Sperling, Jack, & Aisen, 2011), referred to as 
mild cognitive impairment (MCI). Here, MCI is used as umbrella term covering 
subjects with stable cognitive impairment without progression to AD as well as 
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subjects with worsening of cognitive impairment and progression to AD. 
Considering that only the latter will benefit from potential treatment methods, 
the establishment and validation of biomarkers that accurately identify future 
converters to AD among individuals with MCI is crucial. 
 Structural magnetic resonance imaging (MRI) allows the quantification 
of brain atrophy and represents a key imaging marker for the early detection 
of AD. Specifically, reduced gray matter volume in medial temporal lobe 
regions including the hippocampal formation may precede the clinical onset of 
AD by 10 years (Tondelli et al., 2012b). Consequently, the applicability of 
hippocampal subfield segmentation in clinical populations has gained 
increasing attention, with different studies providing evidence for predominant 
cornu ammonis (CA)1 and subiculum atrophy in MCI (Atienza et al., 2011; 
Pluta, Yushkevich, Das, & Wolk, 2012; Yushkevich, Pluta, et al., 2015)  and 
AD (Frisoni et al., 2008; Mueller & Weiner, 2009; Wisse, Biessels, Heringa, et 
al., 2014). Cortical thickness analysis constitutes another widely accepted 
approach to measure gray matter atrophy in AD, and cortical thinning has 
been found in MCI and AD (Lerch, Pruessner, et al., 2008; Liao et al., 2014), 
in late compared to early amnestic MCI (Ye et al., 2014), and in future 
converters (Bakkour, Morris, & Dickerson, 2009; Julkunen et al., 2010; Y. Li et 
al., 2012; Liao et al., 2014). Although gray matter alterations assessed by MRI 
represent valuable biomarkers for AD, the appropriate characterization of the 
progressing pattern of AD pathology across the brain (H. Braak & Braak, 
1991a, 1991b) might require the consideration of multiple structures as well 
as standardized procedures/analysis methods. Additionally, as results from 
hippocampal subfield analyses have indicated, more local information about 
different structures might further contribute to the characterization of AD-
typical patterns of morphometric alterations. 
 Despite evidence for subcortical amyloid and neurofibrillary tangle 
formation in AD (H. Braak & Braak, 1990, 1991b), MRI research has drawn its 
attention to AD related subcortical structure changes only recently. Advanced 
segmentation techniques now permit the quantification of subcortical volumes 
and provide the basis for subcortical shape analysis. Although volume loss 
and/or shape alterations in the thalamus (J. H. Roh et al., 2011; Stepan-
Buksakowska et al., 2014; Zarei et al., 2010), putamen (Cho et al., 2014; de 
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Jong et al., 2011; J. H. Roh et al., 2011) and caudate nucleus (Cho et al., 
2014; Madsen et al., 2010; J. H. Roh et al., 2011) have been identified in AD, 
little is known about subcortical volumetric and shape differences in MCI in 
general, and in future converters in particular. Given the connectivity of the 
thalamus and striatum to other AD-relevant structures, such as the 
hippocampus (Zarei et al., 2010), alterations in these structures may be of 
high value for the early detection of AD. 
 Here, we investigated subcortical volume and shape alterations as well 
as cortical thickness and volumes in the hippocampus and its subfields in MCI 
with stable cognitive abilities compared to healthy control subjects (HC) as 
well as in MCI with future conversion to AD at their baseline and conversion 
timepoints. In this manner we were able to elucidate the potential value of 
subcortical shape measures and their ability to improve the identification of 
future converters to AD. Further, we use cortical and hippocampal measures 
to demonstrate anatomical trajectories of the subjects under study, thereby 
confirming their role in the early detection of AD. 
 We expected stable MCI subjects to show no morphometric alterations 
typically related to AD, such as hippocampal atrophy or cortical thinning when 
compared with HC. In contrast, we expected morphometric alterations in 
accordance with known AD related histopathological processes in future 
converters at baseline and—more pronounced—at time of conversion. 
Specifically, and based on the pattern of AD related neurofibrillary tangle 
formation (H. Braak & Braak, 1990, 1991a, 1991b), we expected volume 
reductions in the hippocampus (CA1, subiculum), the thalamus (anterior 
subregions) and the striatum in future converters at baseline and at time of 
conversion. Further confirming AD related neurodegenerative patterns 
(Bakkour et al., 2009; Dickerson et al., 2008; Lerch, Pruessner, et al., 2008; 
Liao et al., 2014; Ye et al., 2014) in future converters at baseline and at time 
of conversion, we additionally expected cortical thinning in mediotemporal as 
well as lateral parietal and frontal regions and in the limbic system. Most 
importantly, and considering that subcortical volume reductions as well as 
possible secondary downstream effects may lead to thalamic and striatal 
shape alterations, we expected shape alterations in these structures to occur 
in both, future converters at basline and at time of conversion. 
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 Materials and Methods 
 
 Participants 
 We selected participants from different pre-existing longitudinal cohorts 
at the Memory Clinic of the Division of Psychiatry Research and 
Psychogeriatric Medicine, University of Zurich. Briefly, participants were 
recruited from the outpatient population of the Memory Clinic or through 
advertisements in the local media. HC were retrospectively and additionally 
recruited through inquiries of caregivers or relatives of the patients. MCI was 
diagnosed according to Winblad et al. (Winblad et al., 2004), based on 
performance in multiple tests covering the following cognitive domains: 
episodic memory, executive function, attention/psychomotor processing 
speed, language and visual-constructive abilities. Impairment was defined if at 
least one score per domain was 1.5 SD below group means provided by test-
specific normative data. Conversion to dementia was diagnosed when clinical 
work up indicated progression and significant impairment in activities of daily 
living. This was assessed by a multidisciplinary team under the supervision of 
an experienced psychiatrist. 
 For the present study, inclusion criteria for MCI subjects were: 
amnestic MCI (single or multiple domain) diagnosis and availability of MRI 
data at baseline and follow-up. Exclusion criteria were: left-handedness, 
significant medication or drug abuse as well as clinically significant 
neurological and psychiatric or internal disease that may affect cognition, MRI 
findings of infarction or other focal lesions, multiple lacunes or lacunes in 
critical memory structures. A total of 33 baselines from subjects with amnestic 
MCI were considered for the present study. The population was stratified into 
subjects with stable cognitive abilities during an approximately 2-year follow-
up (MCI-S, n = 23), and subjects with future cognitive worsening and 
conversion to probable AD (MCI-CB, n = 10) within a 2-year time frame during 
follow-up. Additionally, data from the MCI-CB group at time of conversion was 
obtained (MCI-CC, n = 10). Inclusion criteria for HC were: stable cognitive 
health ascertained by clinical work up and neuropsychological testing during 
an approximately 2-year follow-up. Exclusion criteria were: MRI exclusion 
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criteria, left-handedness, evidence for abuse of alcohol and drugs, psychiatric, 
neurological or significant other system diseases. Three groups of HC were 
identified for group wise age and gender matching with MCI-S, MCI-CB, and 
MCI-CC, and MRI data was acquired following the description in section 
Magnetic Resonance Image Acquisition. The final demographic details are 
presented in Table 1. This study was approved by the cantonal ethics 
committee of canton Zurich, Switzerland, in accordance with the Helsinki 















































 Magnetic resonance image acquisition 
 All (MRI) were performed on the same 1.5 Tesla Phillips Achieva 
scanner using an 8-element head coil. Whole-brain high-resolution 3D T1-
weighted structural data was obtained by using the following scanning 
parameters: 166 slices, repetition time: 6.9 ms, echo time: 3.2 ms, flip angle: 
8°, field of view: 240 × 240 × 166 mm (anterior-posterior, foot-head, right-left), 
slice thickness: 1 mm, total scan time: 15 min. 
 
 Image processing: subcortical structures and hippocampus 
 Segmentation of the striatum, thalamus and thalamic nuclei was 
performed using a recently developed label-fusion-based segmentation 
method that had previously proven its high accuracy (Chakravarty et al., 
2013). Briefly, the MAGeT-Brain algorithm applies multiple automatically 
generated templates from a single atlas derived from manually segmented 
serial histological data comprising 108 basal ganglia and thalamic structures 
as defined using three different references (Gloor, 1997; Hirai & Jones, 1989; 
Schaltenbrand & Wahren, 1977). We used two of the segmentations 
produced from the MAGeT-Brain pipeline, the first are the whole striatum 
(caudate and putamen) and thalamus, and the second are the thalamic 
subnuclei as per the Hirai and Jones definitions (1989). The thalamus was 
segmented into pulvinar-, anterior-, and central nuclei and lateral dorsal-, 
lateral posterior-, medial dorsal nuclei, ventral anterior nuclei (VA), ventral 
lateral nuclei (VL), ventral posterior nuclei (VP) and lateral geniculate nucleus 
(LGN) and medial geniculate nucleus (MGN) as per the Hirai and Jones 
(1989) nomenclature. Segmentation of the hippocampus and its subfields was 
performed using five high-resolution atlases developed and validated for use 
with MAGeT-Brain (Pipitone et al., 2014; Winterburn et al., 2013). The 
hippocampus was segmented into cornu ammonis (CA) 1, CA2-CA3, 
CA4/Dentate gyrus, strata radiatum/lacunosum/moleculare, and subiculum. 
 
 Surface-based shape analyses 
 Striatal and thalamic shape analysis was performed by using an 
adapted surface-based methodology (Magon et al., 2014; Raznahan et al., 
2014; Shaw et al., 2015). Briefly, surface-based representations of the 
 
 50
striatum and thalamus were defined on the input atlas. The nonlinear portions 
of the transformations that map each subject to the input template were 
concatenated and then averaged to limit the effects of noise and error and to 
increase precision and accuracy. Next, the dot product between the nonlinear 
deformation vector (of the inverse of the averaged atlas-to-subject 
transformation) and the surface normal at each vertex (a unit vector 
describing the direction perpendicular to the surface) was estimated. This 
measure provides an estimate of the local measure of inward or outward 
displacement along the normal. Then, surface-area values were blurred using 
a 5 mm surface-based diffusion smoothing kernel (Chakravarty et al., 2015; 
Raznahan et al., 2014). Resulting inward and outward displacements 
(measured in millimeters) were estimated relative to a detailed subcortical 
atlas previously described (Chakravarty et al., 2015). An inward displacement 
(contraction) represents a surface that is deformed inwards relative to the 
model that we were using and vice-versa for the outward displacement 
(expansion). 
 
 Cortical thickness analysis 
 Cortical thickness was estimated by using the automated CIVET 
pipeline (version 1.1.10; Montreal Neurological Institute at McGill University, 
Montreal, Quebec, Canada). Briefly, the native images were linearly 
registered to the symmetric ICBM 152 template (Collins et al., 1994; Mazziotta 
et al., 2001). Intensity nonuniformities were corrected using the N3 algorithm 
(Sled, Zijdenbos, & Evans, 1998). The skull was removed (Smith, 2002), and 
brain tissue was segmented into white matter, gray matter, cerebrospinal fluid 
(CSF) using the Intensity—Normalized Stereotaxic Environment for 
Classification of Tissues (INSECT) algorithm (Tohka et al., 2004; Zijdenbos et 
al., 1998). Deformable models were used to construct the inner white matter 
surface and gray matter-CSF interface in both hemispheres (Kim et al., 2005) 
revealing 40,962 vertex points at each surface. Cortical thickness was then 
measured as the distance, in millimeters, between each vertex point at the 
inner and the corresponding point at the outer surface using the method 
proposed by Lerch and Evans (Lerch & Evans, 2005). The cortical thickness 
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maps were blurred using a 20 mm diffusion smoothing kernel to increase 
signal-to-noise ratio and statistical power. 
 
 Intracranial volume 
 The comparison of gray matter volumes across groups requires taking 
into account interindividual variability in brain morphology. Values of 
intracranial volume (ICV) indicate premorbid brain volume, and thus are often 
used to adjust volumes for subsequent volume analyses. When examining 
volume reductions in neurodegenerative disease, considering ICV allows for 
estimation of atrophy caused by neurodegenerative mechanisms rather than 
by interindividual differences in head size and brain morphology. 
 In the present work, the FreeSurfer pipeline (version 5.1.0) was used to 
calculate total intracranial volume (eTIV) representing an estimate for ICV as 
described in Buckner et al. (2004). Briefly, each individual is registered to an 
atlas template. The Atlas Scaling Factor obtained by this transformation 
represents the whole-brain volume adjustment that is required to match each 
individual to the atlas template and is thus used to automatically generate 
eTIV. This automated method has been shown to be equivalent to manual 
correction (Buckner et al., 2004) and has previously been used for 
normalization in several AD studies (Westman, Aguilar, Muehlboeck, & 
Simmons, 2013; Westman, Muehlboeck, & Simmons, 2012; Westman et al., 
2011). 
 
 Statistical analyses 
 Group comparisons of demographic and conitive data were applied 
using analysis of variance (ANOVA) or Mann-Whitney U-Test. Pearson's chi-
square test was used for categorical variables. Tests were performed with a 
significance level of p < 0.05. Between-group differences in volumetric raw 
data (MCI-S, MCI-CB and MCI-CC vs. matched HC) were examined by 
including age and gender as covariates in the multiple linear regression 
models. These analyses were repeated by using volumes relative to eTIV 
(volume/eTIV*100) in order to adjust volumes for differences in head size. P-
values resulting from volume analyses were adjusted for multiple testing by 
using Bonferroni-Holm correction (level of significance for hippocampus, 
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striatum and thalamus starting with p < 0.05/2; level of significance for 
hippocampal subfields starting with p < 0.05/10). The same models were 
performed for investigating between-group shape and cortical thickness 
differences. Vertex-wise analyses results are reported on a q-value corrected 
for multiple testing, using a false discovery rate (FDR) of 10% as in previous 
publications in our group (Janes, Park, Farmer, & Chakravarty, 2015; Wheeler 
et al., 2013). Receiver operating characteristic (ROC) curves were computed 
to evaluate and compare the accuracy of striatal and thalamic shape 
alterations, and of hippocampus total volumes as established AD imaging 
marker for discriminating HC from MCI-CB. ROC curves are produced by 
plotting the true positive rate (sensitivity) against the false positive rate (1-
specificity) for different thresholds. The area under the curve (AUC) is then 
calculated and provides information about the ability of the morphometric data 
to discriminate between patients and HC. AUC values of 1.0 indicate perfect 
discriminative abilities; values of < 0.6 indicate poor discriminative abilities. 
For these analyses, between group t statistics from comparison between HC 
and MCI-CB were used. More precisely, for all vertices whose t-values 
constituted a local minimum (or maximum), the average of the displacement 
values in mm was computed for each subject. This was done separately for 
each structure and hemisphere. Statistical analyses were performed with IBM 
SPSS statistics 21 and RMINC package (R for Medical Imaging NetCDF; 
https://github.com/Mouse-Imaging-Centre/RMINC), an image analysis 





 Descriptive statistics for demographic information and cognitive data is 
listed in Table 1. 
 
 Volumetric analyses in MCI-S 
 Apart from reduced bilateral striatal volumes, and when analyzing 
volumes relative to eTIV, there were no volume differences in any of the 
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investigated structures in MCI-S when compared with HC (see Table 2). 
Significance and p-values were similar when using raw volumes instead of 
volumes relative to eTIV (see Table 3). A segmentation map of the thalamus 


























































































































































































Figure 1. Thalamic subnuclei. 
 
Figure 1. Surface labels for automated segmentation of thalamic subnuclei (L 
= left hemisphere; R = right hemisphere), based on expert neuroanatomical 




Figure 2. Hippocampal subfield segmentation. 
 
Figure 2. Coronal views of the hippocampus and hippocampal subfields in 
magnetic resonance images from a healthy control subject (HC) and a mild 
cognitive impairment converter subject at time of conversion (MCI-CC) of the 
present study. 
 
 Volumetric analyses in MCI-CB 
 In contrast, pronounced reductions in volumes relative to eTIV were 
found in MCI-CB (see Table 2). In particular, and apart from CA2-CA3 
volumes, all bilateral hippocampal subfield volumes were smaller in MCI-CB 
compared to HC (right CA1 t = 3.23, p = 0.005; subiculum t = 3.29, p = 0.005; 
CA4/Dentate gyrus t = 3.80, p = 0.002; strata t = 4.55, p < 0.001/left CA1 t = 
5.18, p < 0.001; subiculum t = 4.96, p < 0.001; CA4/Dentate gyrus t = 4.66, p 
< 0.001; strata t = 5.91, p < 0.001; df = 3,16) after correction for multiple 
testing. With regard to thalamic subnuclei, and although statistically 
significant, effects of volume reductions in bilateral VP in MCI-CB (right p = 
0.047, left p = 0.015) did not survive the correction for multiple testing. 
Significance and p-values were similar when using raw volumes instead of 
volumes relative to eTIV. However, some of the right hemispheric differences 
in hippocampal subfield volumes did not quite achieve the level of significance 
(CA1 p = 0.057). Additionally, and although statistically significant, two right 
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hemispheric effects did not survive the correction for multiple comparisons 
(CA4/Dentate gyrus p = 0.017; subiculum p = 0.027) (see Table 3). 
 
 Vertex-wise cortical thickness analyses in MCI groups 
 Analyses on data corrected for multiple testing by using FDR at q < 
0.10 revealed no cortical thinning in MCI-S compared to HC. Reduced cortical 
thickness, however, was found in MCI-CB and MCI-CC compared to HC 
(Figure 3, Table 4). Significant effects were limited to medial areas such as 
the left parahippocampal cortex, left subgenual cingulate, and left region of 
the uncus in MCI-CB. Similar regions revealed cortical thinning in the right 
hemisphere, with significance only at q < 0.15 though (Figure 4). Importantly, 
the pattern of cortical thinning extended to the right hemisphere in MCI-CC, 
where cortical thinning in bilateral parahippocampal cortices and bilateral 
regions of the uncus now achieved an appropriate level of significance. 
 
Figure 3. Cortical thickness results. 
 
Figure 3. Cortical thickness differences in patients with stable mild cognitive 
impairment (MCI-S), future converters at baseline (MCI-CB) and converters at 
time of conversion (MCI-CC) when compared with healthy control subjects 
(HC). Images were generated after including age and gender in the model, 
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and after correction using FDR at q = 0.15 to better illustrate the anatomical 
localization. Bar shows FDR-values, with blue /light blue indicating reduced 
cortical thickness. 
 
Table 4. Reduced cortical thickness in patient groups. 
A 
Anatomic localization MNI coordinates (peak) t statistic (peak) 
  x y z  
Parahippocampal Cortex, left -30 -16 -27 -5.77** 
Subgenual Cingulate, left -18  15 -14 -4.34** 
Uncus, left -29 -29   -8 -6.53** 
 
B 
Anatomic localization MNI coordinates (peak) t statistic (peak) 
  x y z  
Parahippocampal Cortex, left -25 -13 -32 -7.13** 
Uncus, left -31 -12 -23 -7.06** 
Parahippocampal Cortex, right  29 -12 -28 -5.45* 
Uncus, right  31 -10 -22 -5.20* 
Anatomical localization of cortical thinning in mild cognitive impairment 
converters at baseline (A), and in mild cognitive impairment converters at time 
of conversion (B). MNI: Montreal Neurological Institute. * significant after 
including age and gender in the model, and after correction using False 
Discovery Rate at q<.10. ** significant after including age and gender in the 
model, and after correction using False Discovery Rate at q<.01. 
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Figure 4. Striatal and thalamic shape differences. 
 
Figure 4. Differences in thalamic (A) and striatal (B) shape alterations in future 
converters at baseline (MCI-CB) and at time of conversion (MCI-CC) when 
compared with healthy control subjects (HC). Images were generated after 
including age and gender in the model, and after correction using FDR at q = 
0.15 to better illustrate the anatomical localization. Bars show FDR-values, 
with blue/light blue indicating inward displacements (contractions) and 
pink/light pink indicating outward displacements (expansions). 
 
 Vertex-wise subcortical shape analyses in MCI groups 
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 Analyses on data corrected for multiple testing by using FDR at q < 
0.10 revealed no striatal or thalamic shape alterations in MCI-S, but 
pronounced striatal and thalamic displacements in MCI-CB and MCI-CC 
compared to HC. 
 Thalamic contractions and expansions are presented in Figure 4A. In 
contrast to MCI-S, MCI-CB, and MCI-CC revealed contractions which were 
limited to dorsal and medial parts, and were more pronounced in the left than 
in the right hemisphere. Specifically, MCI-CB exhibited contractions in 
bilateral dorsal aspects of the pulvinar, bilateral dorsal aspects of VP, and in 
left medial aspects of VP and medial dorsal nuclei. Again, the pattern of 
alterations had further continued in MCI-CC, exhibiting more pronounced 
contractions extending from dorsal aspects of the pulvinar and VP to dorsal 
aspects of VL, lateral posterior nuclei, and VA in the right hemisphere. In 
contrast, contractions in the left hemisphere were now limited to dorsal 
aspects of VL, VA, and medial dorsal nuclei. However, there was a tendency 
toward significant contractions (q = 0.15) in dorsal aspects of the pulvinar, VP 
and lateral posterior nuclei as well. Thalamic expansions in turn were limited 
to ventral and medial parts. MCI-CB revealed expansions in bilateral ventral 
aspects of the central nuclei, VA, VL, and VP. MCI-CC revealed the same, 
though more pronounced pattern of expansions in both hemispheres, with 
additional expansion in the medial aspect of the medial dorsal nuclei. 
 Striatal displacements are presented in Figure 4B. Again in contrast to 
MCI-S, the other groups displayed contractions, predominantly in the left 
hemisphere and most pronounced in ventral (inferior) aspects. More precisely, 
MCI-CB revealed contractions in medial parts of the putamen and anterior 
parts of the striatum (caudate head). The same pattern was found in MCI-CC, 
with more pronounced alterations in left ventral (inferior) medial parts of the 
putamen and with continued spreading to the left dorsal medial striatum 
(caudate body) and to right ventral (inferior) aspects of the anterior striatum 
(caudate head). Similar to the contractions, striatal expansions were more 
pronounced in the left hemisphere: MCI-CB showed pronounced expansions 
in ventral aspects of the anterior striatum (caudate head) and lateral putamen. 
MCI-CC showed a similar pattern, but with further continued expansions to 
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ventral (inferior) aspects of the left striatum (caudate tail), and to ventral 
aspects of the anterior striatum (caudate head) of the right hemisphere. 
 
 Discriminative accuracy of shape alterations and hippocampus 
volumes 
 For these analyses, between group t statistics from comparison 
between HC and MCI-CB were used. More precisely, for all vertices whose t-
values constituted a local minimum (or maximum), the average of the 
displacement values in mm was computed for each subject. This was done 
separately for each structure and hemisphere. The analyses revealed 
contractions of the right thalamus and left striatum having an AUC of 0.98 
(95% confidence interval [CI] 0.929-1.000, p < 0.001) and of 0.96 (95%CI 
0.883-1.000, p < 0.001) for discriminating HC from MCI-CB (Figure 5), both 
AUC confirming excellent accuracy and high statistical significance similar to 
left hippocampus volume (raw volume AUC = 0.95, 95%CI 0.861-1.000, p < 
0.001; volume relative to eTIV AUC = 0.95, 95%CI 0.848-1.000, p < 0.001) 
and increased accuracy and statistical significance when compared to the 
right hippocampus volume (raw volume AUC = 0.80, 95%CI 0.572-1.000, p < 
0.05; volume relative to eTIV AUC = 0.84, 95%CI 0.633-1.000, p < 0.05). The 
same AUC analyses carried out for thalamic expansions (left AUC = 0.92 
95%CI 0.767-1.000, p = 0.001; right AUC = 0.93 95%CI 0.816-1.000, p = 
0.001), thalamic contractions left (AUC = 0.86, 95%CI 0.685-1.000, p = 0.007) 
and striatal expansions left (AUC = 0.88, 95%CI 0.730-1.000, p = 0.004) 




Figure 5. ROC curve analyses. 
 
Figure 5. Receiver operating characteristic curve analyses of contractions in 
the left striatum (area under the curve [AUC] = 0.96, p < 0.001) and the right 
thalamus (AUC = 0.98, p < 0.001) for discriminating future converters at 
baseline from healthy control subjects. — — — — - ROC curvereference 
lines. 
 Discussion 
 In the current study, we used a combination of novel (thalamic and 
striatal shape indices) and well-established (cortical thickness and the volume 
of the hippocampus and its subfields) structural imaging techniques to 
characterize the neuroanatomy of MCI-to-AD converters. We examined the 
neuroanatomy in the MCI-to-AD converters using data acquired both at 
baseline and time of conversion. In addition, we compared baseline data from 
stable MCI subjects, comparing them with data from group-wise matched HC 
in a cross-sectional manner. 
 
 Cortical thinning in future converters 
 There was no significant difference in cortical thickness in MCI-S 
compared to HC, but in MCI-CB in left parahippocampal regions including the 
uncus with further propagation to bilateral regions in MCI-CC. This pattern is 
consistent with the literature (H. Braak & Braak, 1991b; Mitchell et al., 2002) 
and with morphometric changes previously associated with early stages of AD 
 
 68
(Drago et al., 2011; Mitchell et al., 2002). Like others (Lebedev et al., 2013), 
we also identified cortical thinning in the subgenual cingulate region in MCI-
CB. Functionally, this region has been related to normal sadness reactions 
(Phan, Wager, Taylor, & Liberzon, 2002), and reduced volumes have been 
observed in patients with major depressive disorder (Drevets, Price, & Furey, 
2008). Although clinically significant depression was one of the exclusion 
criteria in our study, very subtle and subclinical depressive symptoms that are 
difficult to quantify may be related to this finding in MCI-CB, leaving the exact 
mechanism unclear. This region has furthermore been associated with the 
uptake of serotonin (Lanzenberger et al., 2013). Serotonin is involved in the 
regulation of sleep (Portas, Bjorvatn, & Ursin, 2000) which is disturbed in AD 
(Westerberg et al., 2012). 
 
 Hippocampal atrophy in future converters 
 MCI-S revealed no global or local hippocampal volume reductions 
compared to HC. However, in accordance with the AD literature (Stepan-
Buksakowska et al., 2014) and our expectations, we found reduced volumes 
of bilateral hippocampi in MCI-CB and MCI-CC as well as reduced local 
volumes of all but one (CA2-CA3) bilateral subfields already in MCI-CB, and 
of all bilateral subfields in MCI-CC. 
 Hippocampal atrophy represents the key imaging marker in AD 
research. The successful identification of hippocampal subfields by using 
high-field MRI, however, has offered a more refined approach (Antharam et 
al., 2012; Mueller et al., 2010; Mueller & Weiner, 2009; Wisse, Biessels, 
Heringa, et al., 2014; Yushkevich et al., 2009). Advances in segmentation and 
analysis techniques have now enabled the field to identify hippocampal 
subfield alterations on images obtained from standard clinical systems. 
Corresponding with the pattern of neurofibrillary tangle formation, 
predominant CA1 atrophy has been found in MCI (Apostolova, Dinov, et al., 
2006; Atienza et al., 2011; La Joie et al., 2013; Pluta et al., 2012; Yushkevich, 
Pluta, et al., 2015), with some of these studies having reported additional 
subicular alterations (Atienza et al., 2011; La Joie et al., 2013) and alterations 
in additional subfields (Amaral, Park, Devenyi, Lynn, Pipitone, Winterburn, 
Chavez, Schira, Lobaugh, & Voineskos, 2016). A more extended pattern also 
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including CA2 and CA3 or even CA4/Dentate gyrus has been identified in AD 
(Apostolova, Dinov, et al., 2006; Frankó, Joly, & Initiative, 2013; Frisoni et al., 
2008; Y.-D. Li, Dong, Xie, & Zhang, 2013). Importantly, alterations in these 
subfields have been related to impaired memory functions in amnestic MCI 
(Atienza et al., 2011; Ferrarini et al., 2014). Local analysis of the structure, 
therefore, has been suggested advantageous for the early detection of 
dementia (Tang et al., 2014). 
 Nevertheless, only a few studies have examined hippocampal subfields 
in future converters. Even though they have applied surface-based subfield 
imaging without providing volumetric information, results of alterations in CA1 
and/or subiculum in future converters to MCI (Apostolova et al., 2010) or to 
AD (Apostolova, Dutton, et al., 2006; Gaël Chételat et al., 2008; Frankó et al., 
2013) are in agreement with our own findings. In line with further progression 
of tangle accumulation (H. Braak & Braak, 1991b), we found similar bilateral 
CA2-CA3 volumes in MCI-CB but reduced bilateral CA2-CA3 volumes in MCI-
CC compared to HC. Additionally, we found bilateral CA4/Dentate gyrus 
volumes were lowered not only in MCI-CC but also in MCI-CB. Although 
CA4/Dentate gyrus volume reduction has mainly been identified in dementia 
stages (Frankó et al., 2013; Y.-D. Li et al., 2013), earlier alterations in this 
subfield have also been reported by others (Pluta et al., 2012). We also 
identified reduced volumes of bilateral strata lacunosum/radiatum/moleculare 
in MCI-CB and MCI-CC, and our results are supported by studies reporting 
stratum radiatum and stratum lacunosum/moleculare of CA1 being affected by 
early tangle accumulation (E. Braak & Braak, 1997; H. Braak, Alafuzoff, 
Arzberger, Kretzschmar, & Del Tredici, 2006; Dietmar R. Thal et al., 2000) 
and atrophy in mild AD (Kerchner et al., 2010b). It shoud be further noted that 
only a few protocols exist allowing for the reliable, automated segmentation of 
hippocampal subfields (see (Wisse, Biessels, & Geerlings, 2014) for a critical 
discussion; (Yushkevich, Amaral, et al., 2015)). Here, we used a multi-atlas 
based segmentation approach (Chakravarty et al., 2013; Voineskos et al., 
2015) that performs as well as other methods used in the field (Pipitone et al., 
2014). 
 
 Thalamic alterations in future converters 
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 MCI-S did not reveal any deviation from HC, neither in thalamic total or 
subfield volumes nor in shape alterations. Contrary to our expectation, the 
same was true for both total and local thalamus volumes in MCI-CB and MCI-
CC. Indeed reduced thalamic total volumes have been reported in amnestic 
MCI (Hahn, Lee, Won, Joo, & Lim, 2016) and MCI-CB (Bossa, Zacur, & 
Olmos, 2011). However, thalamic atrophy in AD is debated, particularly in 
early disease stages (H. Braak & Braak, 1991a; Paskavitz, Lippa, Hamos, 
Pulaski-Salo, & Drachman, 1995; Xuereb et al., 1991), where only a few 
regions are affected by a small number of isolated neurofibrillary tangles (H. 
Braak & Braak, 1991b). Moreover, our results are in agreement with other 
studies having observed similar volumes in amnestic MCI, MCI and AD 
patients (Cho et al., 2014). 
 But first and foremost, and despite the absence of volumetric 
differences, we identified a widespread pattern of shape alterations in MCI-CB 
and MCI-CC with displacements showing similar if not improved 
discrimination between HC and MCI-CB compared to hippocampus volume. 
These findings may represent a critical MRI-based marker for AD. Confirming 
our expectation, the pronounced thalamic shape alterations in VA found in 
MCI-CB and MCI-CC cover regions that are affected from early neurofibrillary 
tangles and later occurring amyloid deposition (H. Braak & Braak, 1991a). 
Importantly, the thalamus plays a crucial role in the Papez circuit with the 
anterior thalamus and the pulvinar, both having shown shape alterations in 
MCI-CB and MCI-CC, being directly connected to the hippocampus (Zarei et 
al., 2010). Furthermore, frontostriatal circuits link dorsolateral prefrontal, 
anterior cingulate, and orbitofrontal cortex regions (Alexander, DeLong, & 
Strick, 1986) via the striatum / globus pallidus (Haber, 2003) to VA and medial 
dorsal aspects of the thalamus (Bonelli & Cummings, 2007; Tekin & 
Cummings, 2002), aspects that again have shown shape alterations in MCI-
CB and MCI-CC. Further significant shape alterations were found in the VP, 
VL and lateral posterior nuclei connecting the structure with the 
somatosensory, motor, premotor and prefrontal and temporal and parietal 
cortices (Behrens et al., 2003; de Bourbon-Teles et al., 2014). Consistent with 
these extensive connections, thalamic regions affected from shape alterations 
in MCI-CB and MCI-CC have been linked with memory and frontal executive, 
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attention, visuospatial perception, and emotion processing (Arend, Henik, & 
Okon-Singer, 2015; de Bourbon-Teles et al., 2014; Saalmann, 2014; Wilke, 
Kagan, & Andersen, 2013), with all of these functions being impaired early in 
AD (Klekociuk, Summers, Vickers, & Summers, 2014). 
 To our knowledge, there has been only one other study investigating 
subcortical shape alterations in MCI-S and MCI-CB, without a HC group 
(Tang et al., 2014). The contractions found in the pulvinar and dorsal aspects 
of the VP in MCI-CB are consistent with contractions that have been identified 
in amnestic MCI by an earlier study of our group (Leh et al., 2016). 
Additionally, the authors have documented contractions in regions that 
remained unaffected in the present MCI-CB sample such as the VL and 
lateral posterior nuclei. These, however, revealed contractions in the MCI-CC 
group. Our finding of contractions in dorsal, medial dorsal and anterior regions 
with more pronounced results in the left than in the right hemisphere in MCI-
CB and MCI-CC, contractions in the pulvinar and dorsal as well as medial 
dorsal regions in MCI-CC in turn are consistent with other study results (Cho 
et al., 2014; Hahn et al., 2016; Qiu, Fennema-Notestine, Dale, Miller, & 
Alzheimer's Disease Neuroimaging, 2009; Stepan-Buksakowska et al., 2014). 
The few results about thalamic expansions in MCI and AD are inconsistent. In 
contrast to expansions in ventral regions in both MCI-CB and MCI-CC, the 
earlier study from our group has identified expansions in more lateral aspects 
in amnestic MCI, whereas others have reported expansions in medial or even 
dorsal aspects in MCI and AD (Qiu et al., 2009). Further studies are 
warranted to find out whether there is a typical AD-related pattern of thalamic 
expansion. 
 
 Striatal alterations in future converters 
 Against our expectation, we observed reduced bilateral striatal volumes 
in MCI-S but similar volumes in MCI-CB and MCI-CC when compared to HC. 
The most plausible explanation for this seem to be age- and gender-related 
shrinking, or age-related changes in dopamine and frontostriatal networks 
(Klostermann, Braskie, Landau, O'Neil, & Jagust, 2012) resulting in reduced 
striatal volumes. Due to age- and gender-matched MCI-S and HC groups, 
however, this is rather unlikely in the present study. Rather, the result may 
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indicate non-AD pathology in our MCI-S sample. This assumption is further 
supported by cognitive profiles differing between MCI-S and MCI-CB. In 
comparison with their respective HC group, MCI-S showed significantly 
reduced cognitive scores not only in memory tests but also in tests assessing 
executive functions, attention and language abilities (see Table 1). In contrast, 
and apart from impaired memory functions, MCI-CB performed worse than 
their respective HC in the category fluency task and in the boston naming test 
but not in attentional tasks. Both, the category fluency task and the boston 
naming test have closely been linked with semantic knowledge (Delis & 
Kaplan, 2001), which in turn is thought to rely on temporal brain regions 
(Levy, Bayley, & Squire, 2004) known to be affected early in AD (Tondelli et 
al., 2012b). Genereally speaking, MCI-S in our study might indeed represent 
non-AD cognitive impairment mainly based on attentional deficits influencing 
other cognitive processes and leading to a more widespread pattern of 
cognitive impairment whereas our MCI-CB group showed an AD-typical 
pattern of cognitive impairment. 
 Normal striatal volumes in MCI-CB and MCI-CC in turn are most likely 
attributable to the early disease stages of each group: striatal amyloid 
deposition and tangle formation have evidenced at late histopathological 
disease stages, and mainly after dementia onset (Beach et al., 2012; H. Braak 
& Braak, 1990, 1991a, 1991b; Dietmar R Thal, Rüb, Orantes, & Braak, 2002). 
Hence, the striatum in MCI-CB and MCI-CC may still be free of typical AD 
pathology. Correspondingly, similar volumes of the striatum, putamen and 
caudate in MCI and future converters compared to HC have been reported by 
others (Bossa et al., 2011; J. H. Roh et al., 2011). 
 As expected, however, shape analyses showed no alterations in the 
striatum in MCI-S but pronounced displacements in MCI-CB and MCI-CC. 
The observed shape alterations were limited to the left striatum in MCI-CB, 
but displacements had propagated within the structure and to the right 
hemisphere in MCI-CC. Furthermore, and as with the thalamic shape 
alterations, these striatal shape alterations revealed similar abilities for 
discriminating HC from MCI-CB compared to hippocampus volume. Aspects 
of the striatum showing most pronounced contractions and expansions such 
as the caudate head, body and tail as well as medial and lateral putamen 
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have been linked to a wide range of cognitive functions. These regions are 
involved in attention, planning and memory (Cummings, 1995), all of which 
are impaired early in AD (Klekociuk et al., 2014). 
 Again, the study from Tang et al. (Tang et al., 2014) represents the 
only study we are aware of having documented shape alterations in MCI-S 
and MCI-CB; however no HCs were compared in this study. In agreement 
with other studies, however, they demonstrated patterns of striatal 
contractions in MCI and AD patients (de Jong et al., 2011; Qiu et al., 2009; 
Tang et al., 2014) that were comparable to the patterns found in the current 
study. Interestingly, only a few studies have documented striatal expansions 
in general (de Jong et al., 2011; Tang et al., 2014), though these expansions 
were less pronounced than in the present study (visual inspection). 
 It is beyond the aim of our study to draw direct inferences about the 
neuronal correlate of shape alterations. Given the pronounced connections 
with other disease-relevant structures (Leh, Chakravarty, & Ptito, 2008), 
however, striatal and thalamic shape alterations may represent secondary 
downstream effects. A similar effect has been proposed by Stepan-
Buksakowska et al. (Stepan-Buksakowska et al., 2014). Specifically, volume 
reductions in the hippocampus and other early affected cortical regions may 
have caused subsequent morphometric changes in connected regions such 
as the thalamus and the striatum, without generating volume reductions yet. 
Although we cannot rule out the possibility of contractions representing 
atrophy-related alterations, the applied surface-based shape analyses provide 
local, but not fully comprehensive information about the entire structure. 
Accordingly, and as it has been shown in the present study, structural shape 
alterations are not necessarily associated with corresponding volume 
changes. Hence, our results of shape differences in the absence of volume 
differences highlight the importance of considering shape changes along with 
established volume measures. 
 
 Limitations 
 The authors are fully aware of other studies investigating subcortical 
shape alterations in MCI and/or AD patients (Cho et al., 2014; Hahn et al., 
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2016; Stepan-Buksakowska et al., 2014; Tang et al., 2014). However, and 
apart from the study from Tang et al. (Tang et al., 2014), we are not aware of 
other studies investigating thalamic and striatal shape abnormalities in MCI-S, 
MCI-CB, and MCI-CC in a single comparative study, and of no study 
comparing these shape abnormalities with measures from age—and gender 
matched HC. More importantly, we are not aware of any other study providing 
evidence of thalamic/striatal shape alterations at such early stages of AD 
(MCI-CB)—with absent thalamic/striatal shape alterations in MCI-S at the 
same time. Thus, our work provides support for these novel morphometric 
measures representing a potential and very sensitive early marker for AD. 
Additionally, and compared with emerging techniques such as hippocampal 
subfield volume analysis and already established techniques such as cortical 
thickness analysis, shape analysis represents an advanced and novel 
technique. Accordingly, the number of studies investigating subcortical shape 
alterations in MCI/AD subjects is limited (Cho et al., 2014; de Jong et al., 
2011; Hahn et al., 2016; Qiu et al., 2009; Tang et al., 2014). Furthermore, the 
comparability of results remains difficult due to different imaging processing 
algorithms and different MRI acquisition modalities (i.e., with field strength of 
scanners varying from 1.5 T in our own study to 7 T in the study from Tang et 
al., 2014, and with other high-sample studies using images acquired from 
various scanners in the study from Qiu et al., 2009). Thus, contractions and 
expansions represent a novel way to quantify the morphometry of brain 
regions, with shape alterations having been associated with memory 
performance in our previous study (Voineskos et al., 2015). 
 Although other groups have also reported shape analysis results 
obtained from studies consisting of similarly small sample sizes (i.e., Stepan-
Buksakowska et al., 2014, 12 AD, 13 HC), the small group sizes may have 
prevented the detection of small effects in this study. However, we believe 
that the reliability of our findings are supported by low standard deviations 
across our measures (see Tables 2, 3) as well as by the overall characteristic 
of the results obtained using well-established analyses techniques (the 
volume of the hippocampus and its subfields and cortical thickness) and being 
perfectly in line with the literature. Furthermore, statistically significant 
differences in shape alterations between small groups indicate that even more 
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pronounced effects might be expected in future studies using larger sample 
sizes. In sum, and despite the small group sizes, we consider the present 
study results important to investigate whether shape alteration can help 
localizing differences associated with the stability or progression of cognitive 
impairment. However, further studies are required to confirm our results in 
larger samples. This is also true for our ROC analyses, whose AUC values 
were remarkably high for measures of striatal and thalamic shape and left 
hippocampus and may represent an overestimation of discriminative ability 
due to small sample size. 
 The approach of using three different control groups might indeed 
increase chances of coincidental findings, and thus represent a limitating 
factor. However, and for the present study, MCI subjects were selected from a 
study aiming to characterize future converters to AD. The study did not 
consist of HC. Therefore, it was necessary to recruit HC restrospectively, 
rendering the acquisition of longitudinal data and performance of longitudinal 
statistical analyses impossible. Furthermore, MCI-CB differed from MCI-S with 
respect to age and gender, both having previously been associated with 
morphometric measures. Thus, and in order to prevent the use of a high 
number of covariates in statistical analyses (and the risk to further reduce 
statistical power), control subjects were recruited for group-wise matching to 
each patient group with respect to these potentially confounding factors. 
 Additionally, the comparison of the data between MCI-S and MCI-CB, 
and between MCI-CB and MCI-CC would be of high interest. However, and 
apart from the cross-sectional nature of the present study, these analyses 
require accounting for confounding variables (i.e., variable times to 
conversion), and increase the number of comparisons. Generally speaking, 
and in consideration of the rather low sample sizes in the present study, 
additional analyses would further reduce the power of the present results. 
Similarly, ROC analyses discriminating MCI-CB from MCI-SB based on 
striatal and thalamic shape alterations is relevant. However, and for similar 
reasons and consistency, the main aim of the ROC analyses in the present 
study was to demonstrate similar if not improved abilities of striatal / thalamic 
shape alterations compared to hippocampal volumes for AD to discriminate 
between MCI-CB from HC. But first and foremost, the aim of the present study 
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was to investigate morphometric differences between patient and well 
matched control groups to establish the sophisticated analysis techniques on 
images obtained from a 1.5 Tesla scanner. Nevertheless, further studies are 
now required to confirm our results in larger samples allowing for additional 
and more advanced statistical models. 
 MCI-S has been described as a potential early stage of AD (Bossa et 
al., 2011). However, apart from slightly reduced striatal volumes, MCI-S 
demonstrated no morphometric changes when compared to HC in the present 
study, rendering this notion unlikely. At the same time, MCI-S, consisting of 
amnestic MCI multiple domain subjects only, showed a more widespread 
pattern of cognitive impairment than MCI-CB, consisting of both, amnestic 
MCI single domain (n = 3) and amnestic MCI multiple domain subjects (n = 7). 
More precisely, both MCI groups showed memory impairment and impairment 
in a language-related function (confrontation naming) as well as in semantic 
memory and executive functioning (animal fluency). Interestingly, however, 
MCI-S but not MCI-CB showed further impairments in additional executive 
tasks (letter fluency, digit span backwards) as well as in attentional abilities 
(TMT A and TMT B). These attentional deficits in MCI-S might be at the basis 
of the other cognitive deficits in this group, resulting in a more widespread and 
global pattern of cognitive impairment when compared with MCI-CB–with 
remaining abilities for everyday life at the same time. Generally speaking, 
these findings might represent non-typical-AD pathology rather than early 
stage AD in the present MCI-S group, and this assumption is further 
supported by the morphometric findings in this group (reduced striatal 
volumes, no other morphometric abnormalities). However, the AD typical 
cognitive impairment, the pattern of cortical thinning and hippocampal atrophy 
in MCI-CB and MCI-CC, together with a cognitive profile uncharacteristic for 
AD and the absence of morphometric alterations in MCI-S, is supportive of AD 
pathology in MCI-CB and MCI-CC. Additional markers of neurodegeneration 
such as CSF levels of phosphorylated Tau together with amyloid imaging may 
provide additional information on this matter in future longitudinal studies. 
Also, vascular risk factors such as hypertension, diabetes mellitus, 
hyperlipidemia, etc. represent main risk factors for the development of 
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dementia. This information, however, was not available for all subjects and 
could therefore not be added in the statistical models. 
 The similarity of patterns of morphometric alterations in MCI-CB and 
MCI-CC is most likely due to both groups consisting of the same subjects, 
with MCI-CC data having been obtained at time of conversion. Hence, the 
time lag of approximately 20.8 months between MRI at baseline and at time of 




 In conclusion, the simultaneous presence of highly accurate thalamic 
and striatal shape alterations, AD typical cortical thinning and hippocampal 
atrophy in MCI-CB but not in MCI-S highlights the value of subcortical shape 
alterations as early marker for AD, and emphasizes the importance to 
consider regional morphological information of subcortical structures. It is 
necessary to find ways allowing the implementation of advanced 
segmentation and analysis techniques in everyday clinical practice in the near 
future. 
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 Abstract 
 Objective: Resting state functional magnetic resonance imaging 
(rsfMRI) is a widely used technique to investigate task-unrelated brain 
networks. Yet, even in rsfMRI studies there is considerable variation regarding 
study purpose and instruction, which might affect neuronal sources linked to 
the brain’s resting state. This may have far-reaching consequences for the 
comparability of different studies on the same topic. The objective of the 
present study was to systematically investigate the influence of providing 
information on the study purpose on static and dynamic resting-state 
functional connectivity (rs-FC). 
 Methods: Thirty right-handed healthy elderly volunteers (61-80 years) 
were scanned during an eyes-closed rsfMRI run. One group was informed 
about a particular study aim (“we study an important brain function”) 
immediately before the rsfMRI run, whereas the other group was not 
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informed. Static regional (i.e., Brodmann areas) as well as network-specific rs-
FC using independent-component analysis (ICA) was performed. Additionally, 
dynamic functional network connectivity was compared between the two 
groups to examine inter-network connectivity. 
 Results: Participants informed before the rsfMRI scan showed both 
increased and decreased regional rs-FC compared to participants informed 
after scanning in several Brodmann areas (BA 8-11, 17, 20, 44-45, p < 0.05, 
corrected). Using a group ICA analysis, participants of the group informed 
after scanning revealed higher rs-FC of the medial prefrontal and anterior 
cingulate cortex component. Further, the strongest effect of the dynamic 
functional network connectivity analysis was seen for this frontal component, 
reflected by its increased connectivity to the left central executive network in 
the group informed after scanning (p < 0.05, corrected). 
 Conclusion: Our results suggest that informing participants about the 
study purpose before rsfMRI influences subsequent task-unrelated brain 
activation within and between functional networks. Hence, we conclude that 
subject information prior to rsfMRI should be taken into consideration when 




 Initial work using task-unrelated resting state functional magnetic 
resonance imaging (rsfMRI) has identified a number of functional networks in 
the human brain that were consistently reproduced in following studies. These 
networks are termed default mode network (DMN), central executive network 
(CEN) or task-positive dorsal attention system (M. D. Fox et al., 2005), 
sensorimotor network (SMN), salience network (SN), and primary visual and 
auditory network (Damoiseaux et al., 2006; M. D. Fox et al., 2005; Lee, 
Smyser, & Shimony, 2013; Seeley et al., 2007; Sridharan, Levitin, & Menon, 
2008). Analyses of resting state networks have been conducted to various 
topics, such as bipolar disorder (Vargas, Lopez-Jaramillo, & Vieta, 2013), 
epilepsy (Centeno & Carmichael, 2014), stroke (Rehme & Grefkes, 2013), 
Alzheimer disease (AD) (Gomez-Ramirez & Wu, 2014), states of 
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consciousness (Heine et al., 2012), aging (Dennis & Thompson, 2014) and 
normal brain development and young adults (Barber, Caffo, Pekar, & 
Mostofsky, 2013; Chai, Ofen, Gabrieli, & Whitfield-Gabrieli, 2014). 
 The body of research on resting state networks is rapidly growing with 
increasing relevance in various disciplines. In order to secure comparability of 
results across studies, it is of great interest to identify and remove 
confounding influences in rsfMRI data. Because there are a number of 
possible "resting states", it is highly relevant to estimate the extent to which 
different resting states feature differences in network connectivity. Several 
aspects of study design have already been identified as factors influencing 
resting-state functional connectivity (rs-FC): In a study by Patriat et al. (2013), 
higher auditory network connectivity was found in an eyes-closed condition 
than an eyes-open and an eyes-fixated condition. Another study revealed 
higher DMN connectivity in an eyes-open and an eyes-fixated condition 
compared to an eyes-closed condition (Yan et al., 2009). Findings of another 
study revealed marginally significant differences between eyes-closed and 
eyes-fixated conditions for the DMN and the CEN (K. Van Dijk et al., 2010). 
 Here, we assessed whether participant information about the study 
purpose prior to rsfMRI is sufficient to alter rs-FC while keeping the instruction 
constant (keep your eyes closed, lie still, and do not move). Specifically, prior 
to scanning we informed all participants that an important brain function was 
going to be investigated during one of the subsequent measurements. We 
then particularly assessed the effect of providing information about the study 
purpose immediately before versus after scanning on rs-FC (using rsfMRI) 
within and between several resting state networks as well as on the whole-
brain level. We assume that delivering controlled information about the study 
aim had an impact on cognitive arousal, resulting in between-group 
differences in rs-FC.  
 Specifically, we expected the informed participants to more strongly 
monitor and invest effort in their behavioural compliance (keep your eyes 
closed, lie still, do not move), and therefore to engage more in cognitive 
processes such as motor inhibition and self-control, and to engage less in 
thought processes typically associated with brain activity during rest, such as 
mind wandering (Christoff, Gordon, Smallwood, Smith, & Schooler, 2009; 
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Mason et al., 2007). Therefore, we hypothesized the following between-group 
rs-FC differences for these Brodmann areas (BA), comparing the after versus 
before group: decreased rs-FC between bilateral dorsolateral prefrontal cortex 
(DLPFC: BA 9 and 46), ventrolateral prefrontal cortex (VLPFC: BA 44 and 
45), which are involved in motor inhibition (Leung & Cai, 2007); decreased rs-
FC between bilateral inferior frontal gyrus (IFG: same BA as VLPFC), which is 
activated in motor inhibition, and medial prefrontal cortex (MPFC: BA 8 and 
11), which is deactivated in motor inhibition (Rodrigo et al., 2014) and 
involved in inhibitory control (Mulligan, Kristjansson, Reiersen, Parra, & 
Anokhin, 2014). Additionally, we expected increased recruitment of the medial 
prefrontal default network area (MPFC), which is involved in mind wandering 
(Christoff et al., 2009), to be reflected in rs-FC differences between groups. 
Accordingly, we hypothesized between-group rs-FC differences in the 
following networks: The CEN, which includes the DLPFC (Sridharan et al., 
2008); the SN, which includes the ACC (Menon & Uddin, 2010; Seeley et al., 
2007); and the DMN, which includes the MPFC and ACC (M. D. Fox et al., 
2005). 
 Materials and Methods 
  
 Participants 
 Thirty cognitively healthy subjects were recruited from ongoing 
longitudinal studies at the Memory Clinic of the Division of Psychiatry 
Research and Psychogeriatric Medicine, University of Zurich. For the present 
study, inclusion criteria were: cognitive health ascertained by clinical work up 
and neuropsychological testing, mini-mental state examination (MMSE) 
scores > 27 and a Hamilton depression scale German version (Ham-D) score 
< 12, MRI suitability, and right handedness. No subject took caffeine or 
nicotine on the day of examination or exceeded the limit for head movements 
of 1.5 millimetres (= half of the fMRI voxel recording size) during scanning. 
The final sample consisted of 30 individuals (61-80 years, 12 female). The 
final groups consisted of 16 participants (9 female) informed after scanning 
and 14 participants (4 female) informed before scanning. Detailed 
demographic information is presented in Table 1.
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Table 1. Participant demographical and control variables. 
Variable Condition M (SD) Statistic, p-value 
Age Informed before scanning 72.1 (4.8)  t(24.3) = -2.7, p = 0.566 
 Informed after scanning 71.1 (5.3)   
Education Informed before scanning 16.2 (2.9)  t(27.9) = -0.6, p = 0.012* 
 Informed after scanning 13.6 (2.2)   
MMSE Informed before scanning 29.5 (0.7) t(25.8) = 0.0, p = 1.000 
 Informed after scanning 29.5 (0.9)  
Ham-D Informed before scanning 1.1 (1.8) t(28.0) = -0.5, p = 0.631 
 Informed after scanning 1.4 (1.6)  
Digit span 
backward 
Informed before scanning 5.9 (1.5) t(27.9) = -2.0, p = 0.055 
 Informed after scanning 6.9 (1.4)  
Corsi block 
backward 
Informed before scanning 27.1 (8.5) t(27.8) = -0.1, p = 0.898 
 Informed after scanning 32.0 (11.9)  
Verbal fluency 
- categorical 
Informed before scanning 23.7 (4.1) t(24.4) = -0.5, p = 0.621 
 Informed after scanning 24.6 (5.3)  
Verbal fluency 
- phonetic 
Informed before scanning 27.1 (8.5) t(23.2) = -1.3, p = 0.214 
 Informed after scanning 32.0 (11.9)  
Stroop 
interference 
Informed before scanning 2.1 (0.6) t(23.5) = 0.7, p = 0.471 
 Informed after scanning 2.0 (0.3)  
TMT ratio Informed before scanning 2.6 (0.6) t(27.7) = 1.3, p = 0.217 
 Informed after scanning 2.3 (0.6)  
*p < 0.05 
Descriptive statistics of control variables for both groups and results of 
statistical tests between groups. 
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 Ethics statement 
 This study was approved by the cantonal ethics committee of canton 
Zurich (E22/2009, SNF-Nr 33CM30-1124111,), Switzerland, and in 
accordance with the Helsinki Declaration. All participants provided written 
informed consent prior to study inclusion. 
 
 Control variables 
 Control variables compared between groups (Table 1) included age, 
gender, education (in years) and scores on the MMSE, the Ham-D and a 
number of tests on working memory and executive function. These 
neuropsychological tests were conducted to exclude the possibility that 
differences between groups in neural activity during rest are attributable to 
differences in cognitive functions related to self-control and inhibition. 
Neuropsychological measures included scores on the digit span backward 
and block-tapping backward test (Wechsler Memory Scale-Revised Edition, 
Wechsler 1987) assessing working memory and the interference score (time 
required for inconsistent condition minus time required for naming coloured 
circles) of the Stroop test (Stroop, 1935), a score of categorical fluency 
(number of animals named within 1 minute; Goodglass & Kaplan 1972) a 
phonetic fluency score (number of words starting with S named within 3 
minutes; adapted from the Thurstone Word Fluency Test; Thurstone & 
Thurstone 1938), and the trail making test (TMT;  ratio: time required for TMT 
B divided by time required for TMT A) assessing different executive functions. 
Gender was compared between groups using the Chi-square test. All other 
control variables were compared between groups using the Welch two sample 
t-tests. For these analyses, the R software package (R version 2.13.1: 
http://www.r-project.org/) was used. 
 
 Experimental manipulation 
 Prior to any scan, all participants were informed that the study purpose 
of one measurement was the investigation of an important brain function, 
which was going to be revealed at a suitable time along the investigation. One 
group of participants was informed about the study purpose immediately 
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before the rsfMRI scan (before group) whereas the other group was informed 
after all MRI measurements (after group). 
 
 Data acquisition  
 Participants were instructed to relax and keep their eyes closed during 
a six-minute rsfMRI scan conducted on a 1.5T Philips Achieva (The 
Netherlands) scanner. fMRI imaging parameters were: echo-planar imaging, 
time of repetition = 3s, time of echo = 50 ms, flip angle = 90°, field of view = 
220 mm, 128 x 128 scan matrix, slice thickness 3 mm, 34 slices, voxel size 
1.72 x 1.72 mm, 120 scans, SENSE (sensitivity encoding for fast MRI 
(Pruessmann et al., 1999)) imaging with a SENSE factor of 1.5, and scan 
duration: 372s. A structural T1-weighted scan (inversion recovery turbo field 
echo, time of repetition = 6.9 s, time of echo = 3.1 s, flip angle = 8°, field of 
view = 240 mm, 400 x 400 scan matrix, slice thickness 1.2 mm, 166 slices,  
voxel size 0.6 x 0.6 mm) was acquired after the rs-fMRI scan. 
 
 Data processing and Analysis 
 
 Static connectivity 
 Whole-brain connectivity was assessed using the functional 
connectivity toolbox CONN (version 14h; http://www.nitrc.org/projects/conn/). 
Pre-processing steps included realignment, temporal filtering (0.01 – 0.1 Hz, 
Biswal et al. (1995)), detrending, slice-timing correction, coregistration, 
segmentation, normalisation, and spatial smoothing (8 mm). The CONN 
toolbox uses the anatomical component-based noise correction (aCompCor) 
method (Behzadi et al., 2007) to correct for physiological noise. This method 
identifies voxels consisting of mainly white matter or cerebrospinal fluid in 
order to model signal fluctuations not attributable to neural activation. This 
approach was shown to be superior to global signal correction (Chai et al., 
2012) and increases the validity, sensitivity and specificity of functional 
connectivity MRI analyses (Whitfield-Gabrieli & Nieto-Castanon, 2012). CONN 
uses the general linear model for second-level analyses. Here, we separately 
analysed the interactions of group assignment with each of the control 
variables to determine whether any connectivity differences between groups 
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were attributable to the interaction with a control variable. Second analysis 
was applied on spherical regions of interest (ROI) predefined by CONN (i.e., 
84 Brodmann areas) using Talairach Daemon 
(http://www.talairach.org/daemon.html) labels. In brief, the fMRI signal was 
averaged across all voxels within a ROI for each time point to calculate an 
average time series. Bivariate correlation coefficients were calculated for each 
pairing of ROIs. These coefficients were Fisher transformed prior to second-
level analysis (Whitfield-Gabrieli & Nieto-Castanon, 2012). 
 Group level independent component analysis (ICA) was performed 
using the Group ICA of fMRI Toolbox (GIFT; version 3.0a; 
http://mialab.mrn.org/software/gift/). For pre-processing, removal of mean per 
time point was chosen. A mask was calculated using all subject and session 
files. Principal component analysis was run on the dataset of each subject 
before group ICA. For group ICA, two data reduction steps were chosen with 
the first step resulting in 30 and the second step resulting in 20 independent 
components. These components were estimated by the infomax algorithm 
(Bell & Sejnowski, 1995) and then submitted to spectral group comparison, 
allowing for significance testing of group differences in non-artefact (neuronal) 
components. FDR-corrected p values of p < 0.05 were considered significant. 
Correction was performed in R (http://www.r-project.org/).Group ICA was also 
performed separately for both groups in order to assess correspondence of 
independent components between the two groups. Resting state networks 
were identified by visual inspection using MRIcron 
(http://www.nitrc.org/projects/mricron). To determine the reliability of the ICA 
algorithm, we used the ICASSO toolbox (research.ics.aalto.fi/ica/icasso) to 
run the algorithm 20 times, starting with different initial values and using a 
bootstrap technique (minimal cluster size 16, maximal cluster size 20). This 
analysis indicated excellent reliability (lowest stability index 0.94).  
 
 Dynamic connectivity 
 In order to take into account variability of rs-FC over time, we 
compared groups using the dynamic FC (dyn-FC) toolbox (Allen et al., 2014). 
We submitted the described neuronal ICs (from the group ICA) to the dyn-FC 
analysis. Pre-processing included detrending and despiking, which was done 
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using 3dDespike (http://afni.nimh.nih.gov/afni), and low-pass filtering at 0.15 
Hz using a fifth-order Butterworth filter. Accurate identification of cognitive 
states has been shown for window sizes of 30-60 s (Shirer, Ryali, 
Rykhlevskaia, Menon, & Greicius, 2012). Because variation of window size 
from 30 to 120 s has been shown to affect dynamics only slightly (C. Chang & 
Glover, 2010; Hutchison, Womelsdorf, Gati, Everling, & Menon, 2013) and a 
recent study found a window size of 22 TR = 44s to be optimal (Allen et al. 
2014), we chose to use a window size of 20 TR = 60 s. Regularization was 
performed using GLASSO (http://cran.r-project.org/web/packages/glasso) 
(Friedman, Hastie, & Tibshirani, 2008), imposing an L1 (lasso) penalty on the 
estimation of the inverse covariance matrix to facilitate sparseness. We 
divided the time course of our resting-state acquisitions into the default 
number of 6 clusters using the k-means clustering algorithm (Lloyd, 1982) and 
compared between-network (IC-specific) connectivity across groups within the 
most dominant cluster, which accounted for 25.7 percent of total dwell time. A 




 Control variables 
 There was a significant difference between groups in education (p = 
0.012). There were no significant differences between groups in gender (Χ2 = 
1.3, p = 0.247), age, MMSE, Ham-D, semantic fluency, phonetic fluency, digit 
span backward, Corsi block backward, Stroop interference, and the TMT ratio 
between groups (all p > 0.05, see Table 1). 
 
 Static rs-FC: ROI-to-ROI analysis 
 ROI-to-ROI whole-brain rs-FC connectivity differed between groups for 
several pairings of ROIs (Figure 1). Stronger connectivity was found in the 
after group for the following connections: left BA 20 (inferior temporal area) - 
BA 9 (DLPFC), left BA 20 - BA 10 (including MPFC and ACC), and left BA 45 
(IFG) - BA 17 (primary visual cortex). Decreased rs-FC was found between 
left BA 17 - right BA 29 (retrosplenial cortex), left BA 17 - right BA 34 (superior 
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temporal gyrus), right BA 17 - BA 29, right BA 45 - left BA 31, left BA 44 (IFG) 
- BA 45, left BA 44 - right BA 45, right BA 45 left BA 11 (MPFC), left BA 44 - 
BA 8 (MPFC) and left BA 44 - BA 9. None of these differences was 
attributable to the interaction of group assignment with any control variable (p-
FDR > 0.05) even for education, which differed significantly between groups.  
 
Figure 1. Whole-brain static ROI-to-ROI connectivity differences.  
 
Connectivity between Brodmann areas was altered in several instances and 
in both directions. Results of two-sided testing with a threshold of p-FDR=0.05 
are displayed. 
 
 Static rs-FC: Group ICA 
 In order to ensure comparability of the two groups with respect to 
meaningful ICs, group ICA was first performed separately for each group. Out 
of 20 ICs, 12 reflected non-neuronal physiological artefacts (respiration or 
pulse) or head motion. Visual inspection of the ICs revealed high 




Figure 2. Independent components in both groups.  
 
Independent components (ICs) correspond well between the before (left hand 
side) and after (right hand side) group. These ICs are the default mode 
network (DMN: A), the central executive network (CEN: B), the salience 
network (SN, C), the sensory/motor component (SMN, D), the auditory 
component (E), and the medial prefrontal cortex/anterior cingulate cortex 
component (MPFC/ACC: F), and the visual component (G). 
 
 The subsequent whole-sample group ICA resulted in identification of 
the same resting state networks that were found within the two groups, with 
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the exception that two separate salience components were extracted (Figure 
3). Results from the ensuing spectral group comparison revealed a significant 
difference in ACC/MPFC (part of the DMN) connectivity with higher rs-FC in 
the after group (Figure 3, Table 2). 
 
Figure 3. Static resting state connectivity differences between groups.  
 
Whole sample ICs (left hand side) are auditory (A), salience (B, B’), SMN (C), 
visual (D), left CEN (E), right CEN (F), MPFC/ACC (G) and DMN (H) 
component. Bar graphs show t-values from spectral group comparison (after 
versus before). The after group shows stronger connectivity in the MPFC/ACC 
and the DMN component.  
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Table 2. Spectral group comparison statistics. 
Component  p 
 t FDR-corrected  uncorrected 
Auditory 0.76 1 0.455 
Salience 1 0.11 1 0.912 
Salience 2 0.96 1 0.343 
Sensory/motor 0.59 1 0.557 
Visual -0.64 1 0.528 
CEN left 1.62 1 0.116 
CEN right 0.57 1 0.570 
MPFC/ACC 3.23 0.027a 0.003 
DMN 2.98 0.053 0.006 
 T-values resulting from between groups comparison and FDR-
corrected p-values. 
aSignificant difference, p-FDR <0.05 
 
 Dynamic rs-FC 
 The dyn-FC analysis revealed group differences among several pairs 
of networks: We found the most accentuated difference between ACC/MPFC 
- left CEN, with increased connectivity in the after group (relative to the before 
group). Additionally, connectivity was increased between the left CEN - DMN, 
auditory network - SMN, auditory - visual network, and auditory network - right 
CEN. Dyn-FC was decreased between the SMN - left CEN and SMN - DMN 
in the after group (Figure 4). Results for clusters 1 (8.7 percent of total dwell 





Figure 4. Differences between groups in dynamic functional network 
connectivity.  
 
1 = auditory, 5 and 17 = salience, 6 = sensory-motor, 7 = visual, 9 and 15 = 
left and right CEN, 16 = ACC/MPFC, 20 = DMN. The first row shows 
correlations between components within groups for the dominant cluster. The 
second row shows significance of differences in these correlations between 





 The main question of this study was how resting-state functional 
connectivity changes in healthy elderly volunteers as a consequence of 
manipulating participant information before scanning. We hypothesized that 
regions involved in motor inhibition, self-control and cognitive processes 
associated with cognition during rest (for example, mind wandering), such as 
MPFC, ACC, DLPFC and IFG, would be affected by our manipulation. We 
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further hypothesized that functional connectivity within DMN would be affected 
because MPFC and ACC constitute part of DMN. 
 
 Static connectivity 
 We found no difference for DMN connectivity between the before and 
after group. However, group ICA revealed an ACC/MPFC component (as part 
of the DMN) that significantly differed between groups. This component was 
found to show differential connectivity between groups to a CEN component 
within the dominant cluster of our dynamic FC analysis. Moreover, the whole-
brain connectivity analysis revealed significant differences in connectivity 
between left BA 9 and 44 and BA 44 and 45, which are parts of DLPFC 
(Levesque et al., 2003; Lissek, Glaubitz, Uengoer, & Tegenthoff, 2013) and 
IFG (Doeller et al., 2003; Zhuang, Tyler, Randall, Stamatakis, & Marslen-
Wilson, 2014). Importantly, additional results indicate that none of these 
differences can be attributed to differences in working memory, executive 
function, interactions between either of these and group. 
 Informing participants about the true study purpose reveals that 
adherence to instructions is crucial to the study. Therefore, although actual 
adherence was expected to be similar in both groups, we hypothesized 
increased effort to adhere to instructions in the before group. ACC/MPFC 
network connectivity differed significantly between groups in our group ICA. 
The areas constituting this network have been shown to be involved in 
behavioural inhibition (Fu et al., 2008). Furthermore, the whole-brain analysis 
revealed greater connectivity in the before group for BA 8, 9, 44 and 45, 
contributing to MPFC, DLPFC or IFG, which are involved in behavioural 
inhibition and self-monitoring (Hollmann et al., 2012; Ochsner et al., 2004). 
Hence, these group differences may reflect increased motor inhibition in the 
participants of the before group. This difference in static rs-FC is not 
attributable to pre-existing differences in cognitive function because there was 
no significant between-group difference in neuropsychological test 
performance (Table 1). 
 We found no between-group difference in either of our salience 
network ICs, which is explained by the fact that ACC activity was captured 
separately in an ACC/MPFC IC. 
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 Both right BA 29 (retrosplenial cortex) and right BA 34 (dorsal 
entorhinal) showed stronger rs-FC to BA 17 (primary visual cortex) in the 
before group. Taking into account that participants had kept their eyes closed 
during scanning, this finding may be attributable to between-group differences 
in visual mind wandering processes during rsfMRI. In addition, in the ICA 
analysis we found stronger (although not significant) rs-FC in the before group 
within the visual IC, underlying the dominance of more mental visual 
processing operations in this group. The retrosplenial cortex is part of a 
network known to be involved in remembering the past and imagining the 
future (Schacter, Addis, & Buckner, 2007). Considering previous findings of 
primary visual cortex being relevant for allocentric representation of the 
environment (Miller, Vedder, Law, & Smith, 2014) and of dorsal entorhinal 
cortex regions being associated with spatial information processing (Gaskin & 
White, 2010), our finding suggests that the before group may have spent 
more time remembering or imagining navigating through an environment. 
 Increased functional connectivity in the before group between left BA 
11 and right BA 45, which is involved in behavioural inhibition, may be 
explained by increased self-control in these individuals. However, it is unclear 
why connectivity is increased between contralateral and not ipsilateral 
regions. Therefore, this finding may represent a false positive. 
 The rs-FC of the DMN did not differ between groups, neither for the 
regional connectivity analysis nor for the group ICA analysis. Together with 
reported findings of DMN connectivity not differing between an eyes-closed, 
an eyes-open, and a fixation condition (R. Patriat, E. K. Molloy, et al., 2013) or 
simply an eyes-closed and an eyes-open condition (Greicius, Krasnow, Reiss, 
& Menon, 2003), this suggests that the DMN is relatively stable with regard to 
procedural aspects of resting-state studies. However, other studies comparing 
eyes-closed, eyes-open, and fixation did find differences in DMN connectivity 
(K. R. Van Dijk et al., 2010; Yan et al., 2009). Additionally, considering that 
the p-value in our study was only slightly above the statistical threshold, our 
failure to find this difference may be attributable to small sample size. These 
inconsistent results create a need for further research concerning the impact 





 Dynamic connectivity 
 Research on dynamic changes in functional connectivity has 
demonstrated notable fluctuations of between-networks connectivity over time 
(C. Chang & Glover, 2010). Considering the fact that cognitive processes are 
unconstrained in the resting-state paradigm, this finding is plausible and 
suggests that investigations using this paradigm should consider such 
fluctuations. Our results from the dyn-FC analysis extend the findings from the 
static rs-FC (group ICA) analysis, demonstrating that there are considerable 
between-group differences in connectivity within the dominant (MPFC/ACC) 
cluster, suggesting that participant information prior to scanning influences 
connectivity during scanning between resting-state networks. The most 
significant difference in connectivity occurred between a frontal part of the 
DMN (ACC/MPFC) and left CEN. The functional relevance of connectivity 
between these networks has been demonstrated in a recent study using 
transcranial magnetic stimulation and rsfMRI, which found a causal 
relationship between CEN and medial prefrontal activity, thereby 
demonstrating an (inhibitory) influence of the CEN on DMN activity, which was 
exerted via its medial prefrontal aspect (A. C. Chen et al., 2013). Given the 
importance of these networks for cognition and the array of disorders DMN 
connectivity is associated with, our finding that connectivity between these 
networks is affected by participant information prior to scanning suggests that 
this study feature deserves considerable attention when planning and 
interpreting studies of rs-FC. 
 Differences between groups in dyn-FC occurred in six additional pairs 
of networks. Our finding of increased connectivity between left CEN and DMN 
in the after group parallels the finding of increased connectivity between left 
CEN and ACC/MPFC. Increased connectivity was also present between the 
auditory network and SMN as well as between the auditory and visual 
network. Functional connectivity between these regions facilitates the 
integration of sensory and cognitive processes. The interaction of components 
of the auditory network and the right CEN, which also showed increased rs-
FC in the after versus before group, is necessary during multisensory 
attention (T. Chen et al., 2014). Finally, the after group displayed decreased 
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rs-FC between the SMN and both left CEN and DMN. Thus, participant 
information potentially influences results from research on a wide range of 
topics and deserves careful consideration when comparing and interpreting 
findings form different studies.  
 
 Limitations 
   
 Functional connectivity shows age dependent changes (Balsters et al., 
2013; Fair et al., 2008). Given that we examined two groups of healthy elderly 
volunteers, caution needs to be exercised when generalising our findings for 
both static and dynamic functional connectivity to populations of younger 
participants. Another limitation is that we studied only one resting state 
condition (i.e., eyes-closed), which makes it difficult to judge about the 
generalizability of the observed connectivity differences across various resting 
states. Finally, we provided only true and meaningful information on the task 
purpose, mainly to ensure that participants’ stayed focused in the scanner. It 
is debatable, but difficult to examine in a systematic way, if only this type of 
information lead to the observed functional connectivity pattern or whether the 




 Future rsfMRI investigations should take into account the influence of 
the type of information given to the participant on subsequent task-unrelated 
functional connectivity. Our results show that connectivity between areas 
associated with inhibition and control is higher in subjects informed before 
than in subjects informed after scanning. These findings suggest that 
participants of rsfMRI studies will show increased effort to comply with pre-
scanning instructions if they are informed about the study purpose before 
scanning. Therefore, participant information prior to scanning significantly 
influences rsfMRI results and should be taken into consideration both when 
designing and comparing studies on resting-state connectivity. This applies to 
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connectivity both within and between networks and measures of both static 
and dynamic connectivity. 
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Figure S1. Results for clusters with second- and third-most dwell time.  
 
Results for clusters 1 (8.7 percent of total dwell time; left-hand side) and 2 
(15.6 percent of total dwell time; right-hand side). 1 = auditory, 5 and 17 = 
salience, 6 = sensory-motor, 7 = visual, 9 and 15 = left and right CEN, 16 = 
ACC/MPFC, 20 = DMN. 
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Table S2. Brodmann area ROIs involved in between group connectivity 
differences.  
Brodmann area Structure ROI center x y z 
8 Left dorsal frontal cortex -23 30 44 
9 Left dorsolateral prefrontal cortex -27 35 29 
10 Left anterior prefrontal cortex -22  56 7 
11 Left orbitofrontal cortex -15  43 -18 
17 Left primary visual cortex 13 -88 2 
17 Right primary visual cortex 13 -88 2 
20 Left inferior temporal gyrus -48 -20 -25 
23 Left ventral posterior cingulate cortex -4 -38 23 
25 Subgenual cortex -5 14 -12 
29 Left retrosplenial cingulate cortex -6 -46 11 
29 Right retrosplenial cingulate cortex 7 -45 12 
44 Left inferior frontal cortex, pars 
opercularis 
-51 10 12 
45 Left inferior frontal cortex, pars 
triangularis 
-50 23 10 
45 Right inferior frontal cortex, pars 
triangularis 
52 23 10 
 







 One goal of the present work was to examine hippocampal, thalamic, 
and striatal shape and surface area as well as cortical thickness as potential 
biomarkers in preclinical AD and MCI. Whereas surface area did not correlate 
with amyloid burden, hippocampal and thalamic shape as well as entorhinal 
cortical thickness were related to measures of Aβ load in cognitively normal 
elderly individuals. Moreover, individuals with MCI who later converted to AD 
differed from healthy controls with respect to striatal and thalamic shape and 
left hemispheric cortical thinning as well as hippocampal total and subfield 
atrophy. In an ROC analysis, hippocampal shape improved upon volume-
based classification of individuals from these two groups. The implications of 
these findings will be discussed in the first part of this section. 
 Because rsfMRI may provide preclinical AD biomarkers that change 
prior to Aβ deposition (Jack et al., 2013) and RSN connectivity and reliability 
have been shown to change as a result of variations in participant instruction 
(R. Patriat, Molloy EK, et al., 2013; K. Van Dijk et al., 2010; Yan et al., 2009), 
another goal of the present work was to investigate the influence of participant 
information on functional connectivity within and between RSNs in healthy 
elderly subjects. We found significant differences in connectivity within a 
component including the mPFC, which is part of the DMN (Michael D Fox et 
al., 2005), and between this component and the left CEN. The implications of 
these findings will be discussed in the second part of this section. 
 The results presented in this work are subject to several limitations and 
give rise to a number of possible directions to take in future research projects. 
Limitations and directions of future research are discussed in the third part of 
this section, followed by a general conclusion. 
 
5.1 Implications: localized structural MRI measures in MCI and 
preclinical AD 
 According to a recent changepoint model of morphometric changes in 
preclinical AD, entorhinal cortical atrophy may accelerate up to 10 years 
before clinical symptom onset (Younes et al., 2014). In our research, cortical 
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thickness did not significantly differ between individuals with stable MCI and a 
healthy control group, but there were significant parahippocampal cortical 
thickness differences between MCI converters at baseline and healthy 
controls. This is consistent with our finding of bilateral associations of 
entorhinal cortical thickness with cortical SUVR in cognitively healthy elderly 
subjects. Our findings are in agreement with previous with previous reports on 
AD related cortical thinning in asymptomatic individuals (Dickerson et al., 
2008; Dickerson et al., 2011) and the progression of tau-related 
neuropathology (H. Braak & Braak, 1991b; Mitchell et al., 2002). The results 
of the present work have repeatedly indicated early involvement of cortical 
thickness in the parahippocampal region in AD progression, considerably 
strengthening the evidence for cortical thickness as a preclinical biomarker in 
AD research.  
  In our investigation of individuals with MCI, no hippocampal 
volume reductions compared to healthy controls were present in individuals 
with stable MCI. In contrast and according to our expectations, converters 
already differed at baseline from their healthy control group in bilateral 
hippocampal volumes. Previous research including individuals with MCI has 
repeatedly indicated predominant involvement of the CA1 (Apostolova, Dinov, 
et al., 2006; Apostolova, Dutton, et al., 2006; La Joie et al., 2013; Pluta et al., 
2012; Yushkevich, Pluta, et al., 2015) and subiculum (Apostolova, Dutton, et 
al., 2006; Frankó et al., 2013). These findings are corroborated by our results 
in cognitively healthy elderly individuals. An association between hippocampal 
shape and CSF Aβ in healthy elderly individuals has been reported in one 
previous study (Carmichael et al., 2012). We have shown that left 
hippocampal shape in areas corresponding with its CA1 and subiculum 
subfields was associated with amyloid burden in this region, which is in line 
with previous findings in MCI patients (de Flores et al., 2015) a previous study 
on progression of non-demented elderly individuals to dementia due to AD 
(Csernansky et al., 2005). One possible explanation for our result is provided 
by a study using transgenic mice, where amyloid deposits added to the 
terminal zone of perforant pathway axons of neurons containing pathological 
tau increased axon dystrophy in these neurons and strongly altered their 
connectivity (Pooler et al., 2013). Additionally, in a recent study hippocampal 
 
 102
amyloid burden in cognitively normal elderly subjects was associated with 
fluid attenuated inversion recovery intensities, indicating tissue edema 
(Schreiner et al., 2014). Hence, our results represent an important finding in 
support of hippocampal shape as an MRI biomarker in preclinical AD. 
 As an important part of the Papez circuit, the anterior thalamus plays 
an important role in memory (Jankowski et al., 2013; Zarei et al., 2010). Yet, 
the thalamus has received little attention in preclinical AD research (Aggleton 
et al., 2016) despite the fact that its anterior nuclei contain a large number of 
NFT in AD (H. Braak & Braak, 1991a). In the present work, we found thalamic 
shape differences between elderly individuals with MCI who later converted to 
AD dementia and a healthy control group. For these two groups, thalamic 
shape reached excellent classification performance in our ROC analysis. In 
healthy elderly individuals, we found significant associations between left 
anterior thalamic shape and cortical SUVR, extending previously reported 
between-group differences in left anterior thalamic shape comparing aMCI 
subjects to a healthy control group (Hahn et al., 2016). Hence, our findings 
may indicate that thalamic shape is a useful measure for prediction of AD at 
the preclinical stage. 
  Our results on striatal shape in MCI add to previously published 
findings indicating striatal shape changes in individuals with MCI (Tang et al., 
2014) and dementia due to AD (Cho et al., 2014; de Jong et al., 2011). 
Striatal shape also achieved excellent classification performance between 
MCI converters and healthy control subjects in our ROC analysis. Yet, we 
found no associations between striatal shape and striatal or cortical amyloid 
burden in healthy elderly individuals. In addition, results from simultaneous 
investigations of multiple structures suggest comparatively late striatal 
involvement in AD progression (Jee Hoon Roh et al., 2011; Tang et al., 2014), 
in line with AD neuropathological stageing (H. Braak & Braak, 1991b). Thus, 




5.2 Implications: the stability of rsfMRI and its future in preclinical 
AD research 
 Although rsfMRI provides promising measures in preclinical AD 
(Chhatwal et al., 2013; Greicius et al., 2004; Thomas et al., 2014) biomarker 
research possibly preceding Aβ biomarkers (Jagust & Mormino, 2011), it is 
not yet incorporated in AD biomarker change models (Counts et al., 2017; 
Jack et al., 2013) or in the proposed framework for stageing of the preclinical 
phase of AD by the NIA-AA working group (Sperling, Aisen, et al., 2011). To 
date, only few studies have investigated rsfMRI in preclinical AD, and 
reliability and reproducibility are affected by pooling of data acquired by 
different scanners (Teipel et al., 2017), and variation in participant instruction 
(R Patriat et al., 2013; Yan et al., 2009). In the present work, we found that 
variation in participant information also affects rsfMRI measurement, providing 
an important extension of these previous findings. The MPFC is a part of the 
DMN and we found that connectivity within ACC/MPFC as well as connectivity 
between ACC/PFC and left CEN significantly differed between groups. Our 
analyses also revealed greater connectivity in individuals informed before 
scanning between areas involved in behavioural inhibition and self-monitoring, 
suggesting that participants in this group showed increased effort to comply 
with pre-scanning instructions. Hence, our findings imply that participant 
information prior to scanning significantly influences rsfMRI results and should 
be taken into consideration both when designing and comparing studies on 
resting-state connectivity. They also suggest that different centers conducting 
preclinical AD biomarker research using rsfMRI should find a consensus 
regarding study design in order to ensure reliability and reproducibility of their 
results, which is an important prerequisite for establishing this method in the 
broader field of AD biomarker research and for conclusive evidence on the 
exact stage of AD progression at which DMN functional connectivity becomes 
abnormal. 
 
5.3 Limitations and directions of future research 
 In the second and third study, sample sizes were small, which may 
explain why the DMN component, in contrast to the ACC/MPFC component, 
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did not significantly differ between groups in our spectral group comparison. 
The generalizability of our findings in the third study is also limited, since we 
investigated only one instruction condition (i.e., eyes-closed). Hence, future 
studies on the influence of participant information on rsfMRI measures should 
incorporate the "eyes-open" and "eyes fixated on a cross" conditions.  
 One limitation of the first two studies is their cross-sectional nature. 
Longitudinal design and the analysis of change parameters would have 
increased the validity of our findings on early AD biomarkers. In addition, 
future studies should investigate which morphological feature best predicts 
conversion from no cognitive impairment to amnestic MCI in cognitively 
unimpaired individuals, using a classifier method such as the ROC analysis 
employed in the second study of the present work. These studies are also 
limited by the resolution of the acquired PET and MRI data: An increase in 
PET spatial resolution allowing for reliable SUVR readout of separate 
hippocampal subregions would enable a more intricate assessment of 
associations between features of hippocampal subfield morphology and 
regional amyloid burden, and an increase in MRI spatial resolution would 
further enhance the quality of automated segmentation using the MAGeT 
Brain algorithm. Future research should also incorporate entorhinal shape as 
a potential early AD biomarker. 
 Additionally, a promising avenue of future research is the combination 
of measures from functional and structural MRI to evaluate whether prediction 




 The findings of the present work suggest that localized changes in 
entorhinal, hippocampal, and thalamic morphology may be valuable predictors 
of cognitive decline and eventually progression to AD dementia in cognitively 
unimpaired elderly individuals. Striatal shape was not associated with 
measures of amyloid burden in this group, but achieved excellent 
classification performance in our ROC analysis including individuals with MCI, 
indicating that this measure may be a valuable prediction feature for 
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progression at the MCI stage. Our findings also extended on previously 
reported pitfalls of rsfMRI research, informing future investigations on 
potential rsfMRI biomarkers in preclinical AD.  
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